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Noninvasive Neuromodulation:  
Modeling and Analysis of Transcranial Brain Stimulation with  
Applications to Electric and Magnetic Seizure Therapy 
 
Won Hee Lee 
 
Bridging the fields of engineering and psychiatry, this dissertation proposes a novel framework 
for the rational dosing of electric and magnetic seizure therapy, including electroconvulsive 
therapy (ECT) and magnetic seizure therapy (MST), for the treatment of psychiatric disorders 
such as medication resistant major depression and schizophrenia. The objective of this 
dissertation is to develop computational modeling tools that allow ECT and MST stimulation 
paradigms to be biophysically optimized ex vivo, prior to testing safety and efficacy in 
preclinical and clinical trials. Despite therapeutic advances, treatment resistant depression (TRD) 
remains a largely unmet clinical need. ECT is highly effective for TRD, but its side effects limit 
its real-world clinical utility. Modifications of treatment technique (e.g., electrode placement, 
stimulus parameters, novel paradigms such as MST) significantly improve the tolerability of 
convulsive therapy. However, we know relatively little about the distribution of the electric field 
(E-field) induced in the brain to inform spatial targeting of ECT and MST. Lacking an 
understanding of biophysical and physiological mechanisms, refinements in ECT/MST technique 
rely exclusively on time-consuming and costly clinical trials. Consequently, key questions 
remain unanswered about how to position the ECT electrodes or MST coil for targeted brain 
 
 
stimulation. Addressing this knowledge gap, this dissertation proposes a new platform that will 
inform an improved spatial targeting of ECT and MST through state-of-the-art computer 
simulations of the E-field distribution in human and nonhuman primate (NHP) brain.  
Part I of this dissertation aims to develop anatomically realistic finite element models of 
transcranial electric and magnetic stimulation in human and NHPs incorporating tissue 
heterogeneity and anisotropy derived from structural magnetic resonance imaging (MRI) and 
diffusion tensor imaging (DTI) data. The NHP models of ECT and MST are created alongside 
the human model since NHPs are used in preclinical studies on the mechanisms of seizure 
therapy.  
Part II of this dissertation aims to apply the model developed in Part I to electric and 
magnetic seizure therapy. We compute the strength and spatial distributions of the E-field 
induced in the brain by various ECT and MST paradigms. The relative E-field strength among 
various regions of interest (ROIs) is examined to select electrode/coil configurations that produce 
most focal stimulation of target ROIs that are considered to mediate the therapeutic action of 
ECT and MST. Since E-field alone is insufficient to account for individual differences in 
neurophysiological response, we calibrate the E-field maps relative to the neural activation 
threshold via in vivo measurements of the corticospinal tract response to single pulses (motor 
threshold, MT). We derive an empirical estimate of the neural activation threshold by coupling 
simulated E-field strength with individually measured MT. The E-field strength relative to an 
empirical neural activation threshold and corresponding volume of suprathreshold stimulation 
(focality) is examined to inform the selection of ECT and MST stimulus pulse amplitude that 
will result in focal ROI stimulation. We contrast the ECT/MST stimulation strength and focality 






(seizure threshold, ST) to study pulse amplitude adjustment as a novel means of controlling 
stimulation strength and focality. This work provides a basis for rational dosing of seizure 
therapies that could help improve their risk/benefit ratio and guide the development of safer 
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Chapter 1  
Introduction 
1.1. Overview of Electric and Magnetic Seizure 
Therapy  
Treatment resistant depression remains a largely unmet clinical need. Despite advances in 
psychotherapeutic, neuropharmacologic, and device-based therapies, electroconvulsive therapy 
(ECT) remains the most effective and rapidly acting treatment for severe, acute, and medication 
resistant psychiatric disorders such as major depression and treatment resistant schizophrenia. 
However, the cognitive side effects of ECT, including post-ictal disorientation, decreased 
processing speed, poor attention, and impaired memory (particularly retrograde amnesia), limit 
its clinical utility. These adverse side effects can lead to functional impairments, increased 
relapse rates, poor clinical outcome, increased burden, and deter patients and practitioners. 
Fortunately, modifications of dosing paradigms can improve the side effect profile, including 
alterations in ECT technique and the use of magnetic fields to induce the seizure (magnetic 
seizure therapy, MST). Unfortunately, key questions about the impact of dosing parameters on 




among parameters and clinical outcome are incompletely understood. This knowledge gap 
impedes optimization of definitive treatment for severe depression and other disabling 
conditions. Furthermore, conventional approaches to dosing seizure therapies have limitations 
that adversely impact clinical care and hamper the progress of research to refine and improve this 
lifesaving treatment. 
 
1.2. Background and Significance 
1.2.1. Major Depressive Disorder 
Major depressive disorder (MDD) is a leading public health problem that contributes to 
substantial disability, morbidity, and mortality. MDD has a lifetime prevalence of 16% (about 34 
million Americans) [2, 3]. MDD is one of the leading causes of disability/burden of illness [4]. 
The World Health Organization (WHO) estimates that MDD will be the second most common 
cause of disability worldwide by 2020 [5]. MDD is life-shortening due both to suicide and the 
association with increased mortality from other medical conditions. These observations make it 
particularly distressing that only 37% of patients achieved remission with their first 
antidepressant medication in the Sequenced Treatment Alternatives to Relieve Depression 
(STAR*D) trial, and that the odds of responding to antidepressant medications diminish with 
each successive trial (31%, 14%, and 13% after the second, third, and fourth trial, respectively). 
Overall, 33% of patients failed to achieve remission despite multiple trials and augmentation 





treatment resistant [2, 3], that yields an estimated 4.6 million Americans with TRD. ECT plays a 
vital role in meeting this pressing clinical need. 
 
1.2.2. Electroconvulsive Therapy 
ECT is administered by delivering electric current to the brain via scalp electrodes to induce a 
generalized tonic-clonic seizure under anesthesia. ECT continues to play an important role in 
TRD because its unparalleled efficacy and speed of response are unmatched by medications, 
transcranial magnetic stimulation (TMS), or vagus nerve stimulation (VNS). For patients who do 
not respond adequately to currently available pharmacotherapy or cannot tolerate their side 
effects, the efficacy and speed of response to ECT are unparalleled [7]. The Consortium for 
Research in ECT (CORE) reported a 75% remission rate to ECT among patients with MDD. 
Over half of patients showed an initial response by the end of week 1, 34% of patients remitted 
by week 2, and 65% remitted by weeks 3-4 [8]. ECT is also rapidly effective in treating 
suicidality [9], the greatest source of morbidity and mortality from depression. It is estimated that 
1-2 million patients worldwide and 100,000 patients in the United States receive ECT each year 
[10]. Given the exceptionally high remission rates and rapid speed of response with ECT, it is 
perhaps surprising that ECT utilization rates are so much lower than the estimated prevalence of 
TRD (only 0.1 million of the estimated 4.6 million Americans with depression receiving ECT 
per year in the US). These numbers suggest that only about 2% of patients who could benefit 
from ECT actually receive it. The cognitive side effects of ECT may be partially responsible for 
this apparent underutilization of this lifesaving treatment. Thus, strategies to reduce these 




American Psychiatric Association practice guideline for MDD recommends ECT for 
difficult-to-treat depression, either after failure of less invasive treatments, or as an initial 
treatment for those patients with severe symptoms, psychotic features, prior good response to 
ECT, need for rapid response, intolerance to medications, or those who have a preference for 
ECT [11]. However, in practice ECT is often used much later in the course of treatment or not at 
all, due both to its stigma and, most importantly, its well-recognized cognitive side effects [12-
14]. Indeed, the cognitive side effects of ECT reduce its tolerability and deter many patients from 
receiving this potentially lifesaving treatment. Retrograde amnesia is the most persistent adverse 
effect of ECT [15-18]. Shortly after ECT, most patients have gaps in memory for events that 
occurred close in time to ECT, but retrograde amnesia may extend back several months or years. 
While retrograde amnesia often improves during the first few months following ECT, for many 
patients recovery is incomplete, with prolonged amnesia for events that occurred close to the 
time of treatment [19]. Specific cognitive deficits can persist for at least 6 months [20]. 
Cognitive impairment is not the only side effect of concern with ECT. Cardiac complications 
represent the most frequent complication seen with ECT [21]. The tachycardia, hypertension, 
and risk of arrhythmias associated with the treatment represent special risks for patients with 
comorbid ischemic heart disease, aneurysms, cardiac arrhythmias, pacemakers/implanted 
defibrillators, and cerebrovascular disease. These side effects deter some patients from accepting 
ECT and deter practitioners from prescribing it. Yet evidence clearly demonstrates that ECT is 
unmatched in its speed of action and efficacy [7]. The need for a better-tolerated but highly 
effective treatment is clear. Fortunately, variations in ECT technique can lower its side effects 





Over the years, various improvements in ECT technique have lowered its risk of side 
effects while preserving efficacy, demonstrating that efficacy and side effects are not 
inextricably linked as was the older dogma [25]. Modifications in ECT technique that resulted in 
lowered side effects include: (1) pulse shape – the shift from sine wave to rectangular pulses [26-
28] and the shift from brief to ultrabrief pulse width [29, 30], (2) electrode placement – the 
introduction of right unilateral (RUL) [31, 32] and bifrontal (BF) electrode placement [33], and 
(3) individualization of dosage – with age-based dosing [34] and dosing the number of pulses 
relative to individual ST [35]. Randomized controlled trials demonstrate that these innovations 
(pulse shape [36] electrode placement [23] and individualization of dosage [37]) play a major 
role in determining the efficacy and side effects of seizure therapy. As shown in Figure 1.1, RUL 
ECT induces less amnesia than BL, but the efficacy of RUL ECT matches that of BL ECT when 
the dosage is given at 500% above the seizure threshold [37]. Increasing the dosage of RUL from 
50% to 500% above the ST increased its efficacy while not substantially increasing its side 
effects [37]. Likewise, we found that reducing the width of the ECT pulse from 1.5 ms to 0.3 ms 
dramatically reduced its side effects, but efficacy was preserved when given at 500% above ST 
for RUL ECT [36]. Of note, each of these memory-sparing innovations was associated with 
greater efficiency in seizure induction. Specifically, ST is lower with RUL vs. BL [37], and with 
ultrabrief vs. brief pulse width (PW) [36]. These observations support the conclusion that 
modifying treatment parameters can reduce side effects, and suggest that improving the 
efficiency of stimulation parameters for seizure induction, and thereby reducing the stimulus 
dosage required to induce the seizure, improves tolerability. These findings highlight the 
importance of individualization of dosage and the complex interactions that can be seen among 





Figure 1.1. Efficacy and amnesia scores as a function of electrode placement and dosage relative 
to seizure threshold [38]. 
and optimize seizure therapies. Answering these questions requires knowledge of the biophysical 
principles relating stimulation parameters with clinical outcomes.  
Despite mounting clinical evidence that dosage parameters interact in determining 
clinical outcomes, unanswered questions remain regarding the mechanisms by which variations 
in treatment technique lead to differences in antidepressant efficacy, cognitive side effects, and 
efficiency of seizure induction. A number of studies have attempted to understand the 
biophysical mechanisms of action of ECT/MST by manipulating stimulation parameters (e.g., 
electrode placement or stimulus current parameters). For instance, experimental electrode 
configurations including bifrontal (BF) [33] and focal electrically administered seizure therapy 





regions. However, their relative focalities have not been measured. It is posited that reducing the 
current amplitude required to induce the seizure (as with ultrabrief pulse width ECT and with 
MST) reduces side effects by virtue of enhanced physiological efficiency, but neural thresholds 
with ECT/MST configurations have not been studied [41]. Contrasting ECT/MST configurations 
that differ markedly in side effects, efficacy, and seizure threshold in their impact on the strength 
and focality of neural stimulation, could advance our understanding of the principles linking 
parameters with outcome, and provide a means of testing these theories. Such work is critically 
important since the parameter space that defines ECT/MST dosing is large to be systematically 
tested through of clinical trials. A mechanistic understanding can narrow the parameter space 
that needs to be tested clinically, and inform the optimization of seizure therapies which play 
such a vital role in TRD.  
 
1.2.3. Magnetic Seizure Therapy 
MST refers to the use of repetitive transcrnaial magnetic stimulation (rTMS) to induce a seizure 
for therapeutic purpose using rapidly alternating magnetic fields applied to the scalp. MST was 
designed to intentionally induce a series of generalized seizures under anesthesia. As a less 
invasive alternative to ECT, MST was developed with the goal of stimulating a more focal 
region of cerebral cortex by taking advantage of superior spatial precision of magnetic fields 
with the unparalleled antidepressant action of seizures. MST offers greater control of the induced 
electric field, since magnetic fields avoid the impedance of scalp and skull and induce the 
electric field confined to superficial cortex, facilitating focal seizure induction. A number of 





Figure 1.2. Faster reorientation following MST than ECT [1]. 
 
ECT with fewer cognitive side effects. For example, seizure induction with MST is feasible [42, 
43]. MST-induced electric fields are weaker, more superficial, and less affected by variation of 
head tissue anatomy than those seen with ECT [44-46]. MST-induced current and the resulting 
seizures are more focal, weaker and less generalized than ECT [44, 47, 48]. MST offers a 
superior cognitive outcome profile than conventional ECT (Figure 1.2) [1, 49-51]. Our group has 
shown preliminary evidence of antidepressant benefits [43, 52, 53]. However, knowledge of 
MST dosing paradigms is still limited and its mechanisms are not completely understood for 







1.3. Approach  
The conventional approach to device optimization that has been undertaken in the refinement of 
seizure therapies [Figure 1.3 (top)] has tested each stimulation paradigm in the context of clinical 
trials, sometimes with preclinical testing in animals as a precursor but often not. This process has 
led to significant innovations but has also been slow and costly. Even though MST employed 
translational studies in preclinical models prior to human testing, the impact of coil placement 
and pulse train frequency was first examined in clinical trials, which can be costly and expose 
patients to risks and the possibility of lack of benefit. We propose a rational approach [Figure 1.3 
(bottom)] which includes multiple, iterative, high-throughput steps to refine the stimulation 
paradigm at the stage of ex vivo computational modeling (Chapter 2) and in vivo evaluation prior 
to testing safety and efficacy in clinical trials. This translational project couples a computational 
model (Chapter 2) with an animal model to address clinically salient questions about the rational 
dosing for seizure therapy. The intermediate steps between transcranial stimulation and clinical 
outcome can be examined by characterizing the induced electric fields (Chapters 3-7) and 
electric field strength relative to neural activation thresholds (Chapters 4-7). Computational 
models can yield essential information about the strength and distribution of the electric field 
induced in the brain by various ECT and MST paradigms (Chapters 4-7), yet such models have 
not been rigorously applied to the clinically important topic of seizure therapies. Animal models 
can then be used to physiologically calibrate the computational model to neural activation 
threshold and to determine the stimulation strength and focality of various ECT and MST 





Figure 1.3. Top (green): Conventional approach to device optimization. Bottom (red): Rational 
approach, with multiple iterative revisions prior to clinical testing. Yellow dotted line: Scope of 
present proposal in this dissertation (figure courtesy of Drs. Lisanby and Peterchev, Duke 
University). 
 
1.4. Thesis Overview 
This dissertation can be organized into two main parts. Part I (see Chapter 2) presents a modeling 
framework for transcranial electric and magnetic stimulation.  
Chapter 2 describes computational modeling methodology for transcranial brain 
stimulation that will be utilized in subsequent chapters. In this chapter, we develop anatomically 





and nonhuman primates (NHPs) incorporating tissue heterogeneity and anisotropy derived from 
structural MRI and DTI data.  
Part II (see Chapters 3-7) presents translational applications to electric and magnetic 
seizure therapy using the models developed in Part I.  
Chapter 3 investigates the electric field strength generated by various ECT electrode 
configurations in specific brain regions of interest (ROIs) that have putative roles in the 
therapeutic action and/or adverse side effects of ECT. This chapter also characterizes the impact 
of the white matter conductivity anisotropy on the electric field distribution.  
Chapter 4 examines the characteristics of the electric field induced in the brain by various 
ECT electrode and MST coil configurations. We compute the maps of the electric field strength 
relative to an estimated neural activation threshold, and used them to evaluate the suprathreshold 
direct stimulation strength and volume (focality) of the various ECT and MST paradigms.  
Chapter 5 computes the spatial distributions of the electric field induced by right 
unilateral (RUL) ECT/transcranial electric stimulation (TES) in four NHP heads and investigates 
the influence of anatomical differences on the electric field strength in the brain across multiple 
subjects at a fixed TES current amplitude. This chapter also derives the neural activation 
threshold by coupling the simulated electric field strength with individually-titrated RUL TES 
motor threshold (MT) and shows that individual anatomical variability as captured by structural 
MRI and the electric field model predicts individual differences in TES MT.  
Chapter 6 investigates the characteristics of the electric field induced in the brain by ECT 
with individualized current amplitude in the NHP models. In this chapter, we generate the maps 
of the electric field strength relative to an empirical neural activation threshold and determine the 




current amplitude corresponding to amplitude-titrated seizure threshold (ST) assessed in the 
anesthetized NHPs. This chapter examines the impact of individualizing and reducing current 
amplitude on the strength and distributions of the electric field induced by various ECT 
paradigms.  
Chapter 7 examines the characteristics of the electric field induced in the brain by MST 
with individualized current amplitude in the NHP models. In this chapter, we compute the spatial 
distributions of the electric field induced by a cap (CAP) MST coil configuration in anatomically 
realistic NHP computational models. This chapter also aims to derive the neural activation 
threshold by coupling the simulated electric field strength in the motor cortex with individually-
titrated MST MT. We create the maps of the electric field strength relative to the neural 
activation threshold and determine the electric field stimulation strength and focality of CAP 
MST with individualized current amplitude corresponding to amplitude-titrated ST. This chapter 
also investigates the impact of individualizing and reducing current amplitude on the stimulated 
brain volume.  
Chapter 8 summarizes the contributions of this dissertation and suggests directions for 
future research.  
Earlier, partial versions of the material in this thesis have been published: Chapter 2 is 
based on work published in [54-58]; Chapter 3 has been published in [54-56]; Chapter 4 is based 
on work published in [59]; Chapter 5 has been published in [60]; Chapter 6 is based on work 











Modeling Framework for Transcranial 













Computational Modeling of Transcranial 
Brain Stimulation 
 
The steps of the electric field modeling and analysis for the human and NHP subjects are 
diagrammed in Figures 2.1 and 2.2, respectively, and described in detail below.  
 
2.1. MRI and Diffusion Tensor MRI Data 
Acquisition 
2.1.1. Human  
To construct an individual volume model of the head, T1-weighted MRI and diffusion weighted 
MRI data sets of a healthy subject (28 year old male) were acquired with a 3 T MRI scanner 
(Magnum 3.0, Medinus Inc., Republic of Korea). The MRI images captured the head above the 






Figure 2.1. Schematic illustration of the methods for generating a realistic finite element (FE) 
model of the human head incorporating white matter (WM) anisotropic conductivity for electric 
field simulation and analysis in specific brain regions of interest (ROIs). T1-weighted MRI and 
diffusion-weighted MRI data sets of the subject are acquired. The T1-weighted MRI images are 
segmented into various tissues types: example segmentation of the human head shows the five 
tissues—scalp (yellow), skull (blue), cerebrospinal fluid (CSF, green), gray matter (red), and 
WM (gray). A diffusion tensor (DT) matrix and a fractional anisotropy (FA) map are computed 
from the diffusion-weighted MRI data. The color-coded FA map represents the principal 
orientations (largest eigenvectors) of the tensors (red: left-right, green: anterior-posterior, and 
blue: superior-inferior). ECT electrodes and MST coil are rendered with computer-aided design 
(CAD) tools and added to the head model. The composite 3-D models of transcranial electric and 
magnetic stimulation are adaptively discretized into FE meshes, and the electric field distribution 
is calculated using the FE method. The electric field is then analyzed both globally and in 
specific brain ROIs. ROI outlines in white from top to bottom show frontal pole, subcallosal 




were obtained using a standard anatomical MR imaging sequence (TR = 35 ms; TE = 7 ms; 180 
slices; 1×1×1 mm
3
 voxel; FOV = 256 mm). The diffusion weighted MRI data were acquired 
using a single-shot spin-echo echo-planar imaging sequence (TR = 8280 ms; TE = 70 ms; 70 
contiguous slices; 1.75×1.75×2 mm
3
 voxel; 2 averages). The diffusion sensitizing gradients with 
a b-value of 600 s/mm
2
 were applied in 45 non-collinear directions. The diffusion weighted 
images were corrected to remove eddy current and subject motion artifacts. We then computed 
the diffusion tensor for each voxel of the DT-MRI data set based upon a mono-exponential 
relationship between the signal attenuation and the diffusion tensor matrix [63, 64].  
T1-weighted structural MRI and DTI datasets of one healthy human subject, including 
the skull base and a portion of the neck underneath, was acquired on a 3T Philips Achieva 
scanner (Philips Medical Systems, Best, Netherlands) using an 8-channel head coil, since 
existing human MRI data was only acquired for the portion of the head above the level of the 
auditory canal. The truncated head model eliminates shunting of the stimulus current in the lower 
portion of the head. The T1-weighted MRI images were acquired with a 3D spoiled gradient 
recalled echo (SPGR) (TR=6.5 ms; TE=3.0 ms; 256 coronal slices; 1×1×1 mm
3
 voxel; FA=8º; 2 
averages). The DTI data was also acquired by employing a single-shot spin-echo echo-planar 
imaging (EPI) sequence (TR=13510 ms; TE=70 ms; 112×112 acquisition matrix; FA=90º; 
2×2×2 mm
3
 voxel). The diffusion sensitizing gradients with a b-value of 1000 s/mm
2
 were 
applied in 32 non-collinear directions. The whole head MRI and DTI data sets were utilized to 







2.1.2. Nonhuman Primates  
All studies were approved by the Institutional Animal Care and Use Committees (IACUC) of 
New York State Psychiatric Institute, Columbia University, and Duke University. T1-weighted 
MRI and diffusion-weighted imaging (DWI) data sets of four healthy male rhesus macaques 
(Macaca mulatta) (age=12–18 years; weight=8.4–10.7 kg) were acquired on a Siemens 3T Trio 
scanner (Siemens, Erlangen, Germany) using an 8-channel knee coil. The NHPs were sedated 
with a combination of ketamine HCl (3 mg/kg body wt. IM) and dexdomitor (0.075 mg/kg to 
0.15 mg/kg body wt. IM) and transported to the MRI unit in approved transport cages. Prior to 
MRI scanning, the NHPs were intubated with a 4 mm to 5 mm tube for administration of 
isoflurane gas anesthesia (0.5% to 3%). The NHPs were oriented in a sphinx position with the 
head forward and were continuously monitored by an Invivo (Essential) MRI-compatible patient 
monitor. Vital signs monitored included heart rate and blood oxygenation (SpO2). The T1-
weighted MRI images were acquired with a 3D magnetization prepared rapid gradient echo 
(MPRAGE) sequence (TR=2300 ms; TE=4.4 ms; TI=1100 ms; 256 coronal slices; 0.7×0.7×0.7 
mm
3
 voxel; FA=8º; 2 averages). The DWI data were acquired by employing a single-shot spin-
echo echo-planar imaging (EPI) sequence (TR=13000 ms; TE=81 ms; 128×128 matrix; 
1.4×1.4×1.4 mm
3
 voxel; interleaved acquisition; pixel bandwidth=1346 Hz). The diffusion 
sensitizing gradients with a b-value of 1000 s/mm
2
 were applied in 12 non-collinear directions. 
Six image volumes with non-diffusion weighting (b=0 s/mm
2
) were also acquired as reference 
images. A twice-refocused technique was used to minimize eddy current effects induced by 
strong diffusion-weighting gradients [65]. The generalized autocalibrating partially parallel 
acquisitions (GRAPPA) parallel imaging scheme with an acceleration factor of 2 was applied to 





Figure 2.1. Overview of the workflow for generating a realistic finite element (FE) model in 
nonhuman primates (NHPs) for electric field computation and combining it with in vivo motor 
and seizure threshold to estimate neural activation threshold and to determine electric field 
stimulation strength and focality. T1-weighted MRI and diffusion-tensor MRI data sets of the 
NHP subjects are acquired. The T1-weighted MRI images are segmented into 14 tissues: 
example segmentation of the rhesus macaque head shows 3-D surface renderings of skin 
(brown), gray matter (dark gray), and white matter (light gray), and 2-D masks of cerebrospinal 
fluid (CSF, blue), gray matter (red), and WM (green). The color-coded fractional anisotropy 
(FA) map and diffusion tensor ellipsoids (enlarged view of the region framed in red) represent 
the principal orientations (largest eigenvectors) of the tensors using the color convention defined 
in Figure 2.1. ECT electrodes and MST coil are incorporated into the head model. The complete 
3-D ECT or MST models are adaptively discretized into FE meshes, and the electric field 
distribution is computed using the FE method. Motor threshold is titrated in vivo by the current 
amplitude of single stimulus pulses. Neural activation threshold is estimated by extracting the 
simulated electric field strength in the target motor area at the empirical motor threshold current. 
Electric field stimulation strength and focality relative to neural activation threshold of the 






factor of 0.75 was used to reduce the EPI echo train length, which further ameliorated geometric 
distortion [67]. DWI acquisition was repeated six times and averaged to increase the SNR. 
 
2.2. Image Processing 
2.2.1. Preprocessing 
We extracted the human and NHP head regions from the background noise and artifacts in the 
T1-weighted MRI data set by applying a morphological processing technique that included 
thresholding, opening and closing of the head binary masks [68]. The preprocessing of the 
extracted head MRI volume was performed based on the open source software components 
available within 3D Slicer 4.0 (http://www.slicer.org/) and in-house image processing algorithm 
[68]. The head MRI images were spatially oriented along manually-defined anatomical 
landmarks, corresponding to anterior commissure (AC), posterior commissure (PC), and 
fiducials for inter-hemispheral midline, so that AC-PC line was perpendicular to the coronal 
plane, and the midline plane was aligned with the sagittal plane. The MRI image intensities were 
corrected for bias field inhomogeneity using improved N3 bias correction algorithm [69].  
 
2.2.2. Gradient Vector Flow Nonlinear Anisotropic 
Diffusion 
It is of particular importance to remove undesirable properties of given MRI images such as 




structures of the MRI images for enhanced tissue segmentation [70]. Content-preserving 
anisotropic diffusion provides such pre-segmentation of the MRI volume and improvement of 
the MRI image quality. In this study, we applied 3-D gradient vector flow (GVF) anisotropic 
diffusion filtering algorithm in order to remove the image noise while preserving content details 
and enhancing tissue boundaries [71].  
 The GVF nonlinear diffusion was proven to be much more robust than conventional 
Structure tensor-based anisotropic diffusion algorithm [72], and is summarized here. 
 The GVF as a 3-D vector field can be defined as:  
                                          )),,(),,,(),,,((),,( kjikjikjikji wvuV           (2.1) 
The field can be obtained by minimizing the energy functional: 
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where f is an image edge map and   is a noise control parameter.  
For 3-D anisotropic smoothing, the Structure tensor S is formed with the components of 
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S                                                        (2.3) 
                                                                 T)(VVS            (2.4) 
where I is an image, i and j are image indices, x and y denote partial derivatives in space.   
The 3-D anisotropic regularization is governed using the GVF diffusion tensor DGVF 









 D ,  (2.5) 
where J is an image volume in 3-D. The regularization behavior of (2.4) is controlled with the 
eigenvalue analysis of the GVF Structure tensor [70, 73]. 
 
2.3. Tissue Segmentation 
2.3.1. Human  
To generate a realistic volume conductor model of the head, the various distinct tissues have to 
be mapped, since they have different electrical properties. Segmentation involves creating 3-D 
masks that correspond to each tissue layer of the head. The structural MRI images were 
segmented into several tissue regions (see Table 2.1). We first removed non-brain regions using 
the skull-stripping algorithm BET tool [74] in FSL (FMRIB Analysis Group, University of 
Oxford, UK, http://fsl.fmrib.ox.ac.uk/fsl/fslwiki). This initial segmentation was further corrected 
for accurate brain extraction using manual editing tools in the ITK-SNAP software [75]. The de-
skulled MRI images were automatically segmented into partial volume images corresponding to 
gray matter, white matter, and cerebrospinal fluid (CSF) using an automated segmentation tool 
FAST in FSL. We then segmented non-brain regions into 11 different tissue regions, including 
skin, muscle, skull compacta, skull spongiosa, vertebrae, spinal cord, lens, eyeball, sclera, optic 
nerve, and sinus, using a combination of segmentation editing tools from the ITK-SNAP 
software and an in-house segmentation algorithm based on thresholding and mathematical 




2.3.2. Nonhuman Primates  
The implementation for tissue segmentation described in Chapter 2.3.1 has been developed and 
fine-tuned for the human brain. Since the NHP brain has relatively smaller brain sizes and 
somewhat different brain anatomy than human, the segmentation tools for human MRI brain 
scans are not well adapted for segmentation of the NHP brain segmentation. As such, we 
implemented an automatic algorithm that uses the unified segmentation routines [76] 
implemented in SPM8 (Wellcome Department of Cognitive Neurology, Institute of Neurology, 
University College London, UK, http://www.fil.ion.ucl.ac.uk/spm) to produce probability tissue 
maps that define the probability of occurrences of a given tissue for each voxel of the image. The 
de-skulled NHP MRI images were segmented into tissue probability images in native space 
corresponding to gray matter, white matter, and cerebrospinal fluid (CSF) based on the 112RM-
SL macaque tissue priors [77]. In this process, the unified segmentation approach uses an 
objective cost function integrating the prior tissue probabilities, a mixture of Gaussians, and a 
registration term [76]. Instead of the default settings in the “Segment” tool in SPM8, our 
algorithm utilized user-defined parameter settings: (i) human tissue priors (ICBM452 T1-
weighted average) were replaced by the 112RM-SL macaque tissue priors [77]; (ii) affine 
regularization was changed to “Average sized template”; (iii) sampling distance was reduced to 2 
mm [78]. Manual segmentation of the non-brain regions into 11 tissue compartments, 
representing skin, muscle, skull spongiosa, skull compacta, vertebrae, spinal cord, lens, eyeball, 
sclera, optic nerve, and sinus, was carried out using a combination of segmentation editing tools 






2.4. Electrode and Coil Modeling 
2.4.1. ECT Electrode Configurations 
To model transcranial electric stimulation, 3-D CAD renderings of the ECT electrodes have to be 
added at the appropriate positions on the head representation. We added realistically-shaped ECT 
electrodes to the 3-D head model by intersecting cylindrical or rectangular solid geometries with 
the head rendering. We modeled three conventional electrode placements (BL, BF, and RUL) 
[79, 80] and two investigational configurations (FEAST and FM) [81, 82] diagrammed in Figure 
2.1. Standard round electrodes (5 cm diameter) for the BL, BF, RUL, and FM ECT electrode 
configurations were modeled for the human models. Two round electrodes for the BL (3.5 cm 
diameter) and BF, RUL, and FM ECT (2.5 cm diameter, respectively) configurations were 
modeled for the NHP models. 
For BL ECT, the two electrodes were centered bilaterally at the frontotemporal positions 
above the midpoint of the line connecting the external canthus and tragus (APA, 2001). For BF 
ECT, the electrodes were placed bilaterally above the outer angle of the orbit on a line parallel to 
the sagittal plane (Abrams, 2002). For RUL ECT, one electrode was centered to the right of 
vertex and the second electrode was placed in the homologous right frontotemporal position 
(APA, 2001). For FEAST, a wide rectangular electrode (2.5 cm × 6.3 cm) was placed over the 
right motor strip and a small circular electrode (2 cm diameter) was placed over the right 
eyebrow. For human FM ECT, one electrode was placed medially on the forehead and the 
second electrode was placed in front of vertex. For NHP FM ECT, the two electrodes were 
placed medially on the forehead and posterior to vertex, respectively. Since the conductivity of 




Chapter 2.6), the electrode surface is effectively equipotential for any practical electrode 
thickness. Therefore, we did not accurately model the electrode thickness but, for simplicity, 
kept the outer surface of the electrodes flat, resulting in the electrode thickness between the flat 
outer surface and the scalp curvature varying from 5 mm to 12 mm. The electrode wires were 
modeled as current sources respectively sourcing and sinking current in the centers of the outer 
electrode surface, reflecting the wiring of conventional ECT electrode paddles, even though the 
high conductivity and the resulting equipotential surface of the electrodes make inconsequential 
the exact point of injection of current from the wires to the electrodes. Finally, we did not model 
the electrolyte gel applied to the ECT electrode surface, since the gel’s purpose is to stabilize the 
impedance of the electrode–scalp interface, which is already assumed in the computational 
model, and since the gel is largely displaced when the electrodes are pressed against the head.  
 
2.4.2. MST Coil Configurations  
To model transcranial magnetic stimulation, 3-D CAD renderings of the MST coils have to be 
integrated with the head models. MST coils consist of copper wire windings covered with layers 
of high-voltage insulation [83, 84]. The shape of the windings has a key role in determining the 
distribution of the induced electric field. 3-D CAD drawings of the coils were created in ANSYS 
(ANSYS Inc., Canonsburg, PA), then were integrated with the head models. The distance 
between the windings and the head was set to account for the thickness of the insulation [85, 86]. 
The coil model was validated by comparing the simulated coil inductances to the actual 






For the human models, we modeled a circular coil on vertex (CIRC) MST coil (S/N 
MP39, Magstim Co, Whiteland, Wales, UK) configuration using manufacturer’s data and 
inductance measurements, selected because it has been used in clinical studies. The CIRC coil 
consists of two parallel layers of windings connected in series, each with an inner diameter of 44 
mm, outer diameter of 120 mm, and 9 turns. The coil conductors were placed above the vertex of 
the human head model.  
For the NHP models, the cap (CAP) MST coil (MagVenture A/S, Farum, Denmark) 
configuration was modeled using manufacturer’s data and inductance measurements, selected 
because it has been used in preclinical studies. The CAP coil consists of a single-layer, concave 
circular winding with an inner diameter of 21 mm, outer diameter of 95 mm, and 15 turns. The 
coil conductors were placed above the vertex of the NHP head models.  
 
2.5. Finite Element Mesh Generation 
Once the volumes defining the head tissues and the ECT electrodes and MST coils are rendered, 
they have to be discretized into a large number of smaller subvolumes (finite elements, FEs) 
resulting in a 3-D mesh model used to solve the electric field with FEM. For the FE mesh 
generation, we utilized the Computer Geometry Algorithm Library (CGAL) 
(http://www.cgal.org). The mesh generator is based on the labeled voxel-volume meshing 
technique [87] and allows generation of FE tetrahedral meshes which contain one sub-mesh for 
each sub-domain and surface meshes that approximate the boundaries of the domain and sub-
domain. The triangulation algorithm provides a discretized approximation of tissue 




paradigm [87, 88], resulting in 3-D meshes of each tissue domain and conformal surface meshes 
for all tissue boundaries and subdividing surfaces.  
 
2.6. Tissue Properties 
The physical properties of biological tissues that are relevant to the electric field induced by 
electric and magnetic stimulation are the conductivity and permittivity. Permeability in 
biological tissues does not significantly deviate from that of free space. Tissue electrical 
conductivities were derived from the literature. The permittivity of tissues was assumed to be 
zero, consistent with the quasistatic approximation discussed in Chapter 2.7. Since the high 
anisotropy of WM can significantly distort the electric field relative to a model assuming 
isotropic WM conductivity, we created volume conductor head models by assigning anisotropic 
electrical conductivities to the white matter compartment, and isotropic conductivities to all other 
tissue regions. The isotropic electrical conductivities (in S/m) are given in Table 2.1 [68, 89-91].  
 The estimation of the anisotropic conductivity tensors in the white matter started with 
preprocessing of the raw DWI head data. The DWI data were processed using FSL’s diffusion 
toolbox (FDT) from the FMRIB Software Library. Artifacts and spatial distortions due to eddy 
current effects caused by strong diffusion gradients used in the EPI sequence and possible head 
motion were corrected by performing an affine registration between diffusion-weighted images 
and non-diffusion-weighted images. For the human and NHP DWI data sets, the diffusion-
weighted volumes of each subject were coregistered to the non-diffusion-weighted volume, 
which was used as the reference volume. A binary brain mask was extracted from the volume 





resulting from the automated segmentation algorithm were further corrected to ensure that we 
only reconstructed diffusion tensors inside the brain rather than the surrounding air. We then 
computed the diffusion tensors for each voxel of the preprocessed DWI datasets [64]. The 
resulting diffusion tensor volumes were coregistered to the structural T1-weighted MRI volume 
using an affine registration with mutual information as the cost function while the orientation of 
each diffusion tensor was preserved [92]. 
 To estimate the WM anisotropic conductivity tensors, we used the assumption that the 
conductivity tensors share eigenvectors with the measured diffusion tensors [63, 64]. We 
deployed the volume constraint approach to estimate the WM anisotropic conductivity with a 
fixed anisotropy ratio in each WM voxel [90]. The WM anisotropic conductivity tensor 
WM was 
modeled to be prolate 
   1WM long trans trans diag , ,       S S                               (2.6) 
where S denotes the orthogonal matrix of unit length eigenvectors of the measured DTs at the 
barycenter of the WM tetrahedral elements. Parameters long  and trans  are the conductivity 
eigenvalues longitudinal (parallel) and transverse (perpendicular) to the WM fiber direction, 
respectively, with long trans  . We computed long and trans  from the WM isotropic 
conductivity value of 
iso = 0.14 S/m and the anisotropic factor k [90, 93] 
     3/2isolong k                                   
(2.7) 
     3/1isotrans
 k .
                               
(2.8) 
Another alternative is the volume normalization approach to derive variable white matter 
anisotropic electrical conductivity tensors using a linear conductivity-to-diffusivity relationship 




The electrical conductivity tensors   in the white matter were computed from the measured 
diffusion tensors D and the isotropic white matter conductivity iso  from the literature using the 
volume normalized algorithm [57, 93-97]: in each voxel, the diffusion tensor is linearly scaled so 
that the volume of the resulting conductivity tensor ellipsoid matches that of an isotropic 










               (2.9) 
where id are the diffusion tensor eigenvalues. This approach preserves the orientation 







Table 2.1. Tissue electrical conductivities (S/m) 
Tissue Conductivity  Tissue Conductivity  
Skin 0.43 Lens  0.32 
Muscle 0.32 Eyeball 0.5 
Skull compacta 0.0063 Sclera 0.5 
Skull spongiosa 0.04 Spinal cord  0.15 
Cerebrospinal fluid 1.79 Vertebrae 0.012 
Gray matter  0.33 Optic nerve 0.14 











2.7. Electric Field Simulation  
2.7.1. Theoretical Background 
Since the current waveform frequencies in ECT and MST are relatively low (< 10 kHz), 
electromagnetic field solutions can be obtained by solving the quasi-static Maxwell’s equations. 
This quasi-static approximation involves neglecting wave propagation, inductive and capacitive 
effects in the conductive medium. This means that the electric field varies with no significant 
phase differences and the effect of the magnetic field generated by the currents in the tissue can 
be ignored. The tissue is also considered as a purely resistive medium [98].  
In the conductive medium, considering static and dynamic fields and neglecting 

















          (2.11) 
 0 B

          (2.12) 
where   is the tissue permittivity, B

 is the magnetic flux density,   is the tissue electrical 
conductivity, and E

 is the electric field.  
 In the air, the Ampere equation relates the magnetic field H

 with the current density 
 sJH

           (2.13) 
 0 B

          (2.14) 
where H

 is the magnetic field intensity and sJ

 is the current density in the simulating coil. 
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which indicates that the normal component of the magnetic flux density is zero at infinity. n

  is a 
unit vector normal to the surface.  





  and electric field E

 can be expressed as follows: 
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         (2.17) 
In the quasi-static limit, the divergence of the induced current density is equal to zero. 





























        (2.19) 
At the interface between two regions with different conductivities, the boundary 
condition follows the continuity of current 
 2211 nJnJ

          (2.20) 
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At the air and tissue boundary, the current density normal to the interface is equal to zero 























 At the exterior boundary of the air model, 
 0 An

         (2.23) 
which indicates that the magnetic field is approximately zero at the model boundary.  
Equations (2.18)-(2.23) can be solved in combination with coulomb’s gauge 
 0 A

         (2.24) 
 
2.7.2. Harmonic Analysis Using Complex Formalism  
In a general dynamic problem, any field quantity, q(r, t) depends on the space r and time t 
variables. In a harmonic analysis, the time dependence can be expressed by periodic function 
[101]:  
)sin()()cos()())(cos()(),( wtrstrcrtratrq          (2.25)  
where   is the angular frequency of time change, )(ra  is the peak amplitude, )(r  is the phase 
angel, )(rc  is measurable field at 0t degrees, and )(rs is measurable field at 
90t degrees.  
The quantities in equations (2.25) are related by  
 ))(cos()()( rrarc           (2.26) 
 ))(cos()()( rrarc           (2.27) 
 ))(sin()()( rrars           (2.28) 











In equation (2.25), )(ra , )(r , )(rc , and )(rs  depend on space r, independent of time t. 
This separation of variables, space r and time t, enables us to reduce four (3 space and 1 time) 
dimensional real problem to a three (space) dimensional complex problem. This can be solved by 
the complex formalism.  
The measurable quantity, q(r, t) can be expressed as the real part of a complex function: 
 })(Re{),( jwterQtrq          (2.31) 
 )()()( rjQrQrQ ir          (2.32) 
where j is the imaginary unit, Re{} denotes the real part of a complex quantity. )(rQr  and )(rQi  
are the real and imaginary parts of )(rQ .  
The complex exponential function in equation (2.31) can be expressed by sine and cosine 
functions as 
)sin()cos( tjte jwt           (2.33) 
Substituting equation (2.33) into equation (2.31) provides equation (2.32) 
)sin()()cos()(),( trQtrQtrq ir          (2.34) 
By comparing equation (2.25) with equation (2.34),  
)()( rQrc r          (2.35) 
)()( rQrs i          (2.36) 
The complex real part )(rQr  and imaginary part )(rQi are equal to the measurable cosine 
)(rc and sine function )(rs , respectively.  
 A harmonic analysis provides the real and imaginary components of a complex solution. 
The magnitude of the real and imaginary parts describe the measurable field at t=0 and at t = -













r          (2.38) 
Equation (2.37) expresses the peak amplitude and phase angle of the measurable harmonic field 
quantities by the complex real and imaginary components.  
 
2.7.3. Quasistatic Electric Analysis 
Neglecting the time-derivative of magnetic flux density under the quasi-static approximation, the 
electric field can be derived as follows [101]: 
VE 

         (2.39) 
where V is the electric scalar potential.  
The constitutive equations for the electric fields become 
EJ

          (2.40) 
ED

          (2.41) 
where   is the electrical conductivity matrix, D

 is the electric flux density vector, and   is the 
permittivity matrix.  
In a quasi-static electric analysis, the relevant governing equations are equation (2.39) 
and the continuity equation 


















Substituting the constitutive equations (2.40) and (2.41) into equation (2.42), and taking 
into account equation (2.39), the following differential equation for the electrical scalar potential 
can be obtained 











V          (2.43) 
Neglecting time-variation of electric potential reduces the governing equation for steady-state 
electric conduction: 
   0)(  V          (2.44) 
In a time-harmonic electric field analysis, equation (2.43) can be rewritten as 
       0)(  V
w
j
V          (2.45) 
where j is the imaginary unit and w  is the angular frequency.  
 
2.7.4. Electric Field Computation 
The numerical solution of the electric field induced by electric and magnetic stimulation was 
computed with the FEM software packages ANSYS (ANSYS Inc., PA, USA). Since the current 
waveform frequencies used in ECT and MST are relatively low (< 10 kHz), we adopted the 
quasistatic approximation, as described in Sections 2.7.2 and 2.7.3, which essentially ignores the 
frequency dependence of the tissue impedance when solving the electric field [102-104].  
 For all ECT electrode configurations, the current was set to 800 mA, corresponding to the 
conventional setting used with the MECTA Spectrum 5000Q ECT device (MECTA Corp., OR, 
USA). The electric field was obtained by solving the quasi-static Laplace equation with no 





  0)(  V          (2.46)  
where V and   are the electrical potential and the tissue conductivity tensor, respectively. The 
Neumann boundary conditions apply on the surface of the model  
  0)(  nV

                   (2.47) 
where n

 is the unit vector normal to the outer surface of the model, except at the outer centers of 
the electrodes where current is injected. For each of the electrode configurations, the system of 
linear equations of the FE method was solved using the preconditioned conjugate gradient solver 
with a relative tolerance of 10
-8
. Finally, the electric field distribution was computed by taking 
the gradient of the scalar potential V. 
For the MST coil configurations, a time-harmonic simulation with appropriate boundary 
conditions was first performed to compute the spatial electric field distribution generated by 
MST for an arbitrary coil voltage 1 V and frequency ω0 = 2π × 5 kHz, resulting in electric field 
distribution with unadjusted amplitude, )(' rE . The electric field was then scaled to match the 
output of the Magstim Theta or MagPro device [86]: 







            (2.48) 
where Vc is the nominal energy-storage capacitor voltage at maximum pulse amplitude of the 
Magstim Theta (Vc = 1.65 kV) or MagPro (Vc = 1.8 kV) device. I is the coil current and L is the 








Translational Applications to Electric and 














Regional Electric Field Induced by 
Electroconvulsive Therapy  
3.1. Introduction 
Electroconvulsive therapy (ECT) is a therapeutic intervention in which electric current is applied 
through scalp electrodes to induce a generalized seizure in anesthetized patients [79, 80]. 
Although ECT plays a vital role in the treatment of medication-resistant psychiatric disorders, 
such as major depression, the use of ECT has been limited by its cognitive side effects 
(particularly amnesia [20, 107]), by cardiac complications [108], by the need for general 
anesthesia, as well as by the high rate of relapse [109]. Despite the introduction of various 
improvements of ECT technique, there is still limited knowledge of how to optimally select 
electrode placement [110] or stimulus current parameters [111] for maximal efficacy and 
tolerability. Indeed, the therapeutic action and adverse side effects of ECT are highly dependent 
upon electrode placement and stimulus current parameters, but a complete mechanistic 
explanation for these relationships is still lacking. For instance, right unilateral (RUL) ECT leads 




whether this is by virtue of lower electric field (E-field) strength in hippocampus and other 
regions crucial for memory. Furthermore, alternative ECT electrode configurations such as 
bifrontal (BF) [79] and focal electrically administered seizure therapy (FEAST) [81] have been 
proposed with the goal of preferentially targeting frontal brain regions to reduce memory 
impairment, but the frontal electric field strength relative to the rest of the brain and relative to 
other electrode placements has not been quantified.  
To understand the underlying biophysical mechanisms of ECT, a few early studies 
undertook measurements of the electric field generated by ECT in human cadavers [113, 114] 
and in an electrolytic tank containing a human half-skull [115]. However, the electrolytic tank 
measurements did not account for the geometry and conductivity properties of the scalp and the 
brain. The intracerebral cadaver measurements were carried out after an uncontrolled interval of 
time following death, potentially resulting in altered conductivity profile of the head tissues, and 
the tissues were damaged in the process of inserting the recording probes, potentially altering the 
paths of current flow generated by the scalp electrodes. Furthermore, neither of the studies 
produced a high-resolution map of the electric field or the current density distributions in the 
brain.  
In order to provide more detailed field maps, a number of computational studies have 
simulated the distribution of the electric field or the current density field (which equals the 
product of electric field and conductivity) in the brain using a volume conductor model of the 
head. The representation of the head in computational ECT models ranges in detail from 
concentric spheres [116-118] to low-resolution realistically-shaped representations [119-121] to 
high-resolution anatomically-accurate models [122, 123]. Furthermore, a substantial number of 





transcranial electric stimulation paradigms, again ranging from simplified to realistic head 
representations [91, 96, 115, 124-140]. However, these studies have various limitations. The 
spherical and simplified geometry models do not fully account for tissue inhomogeneity and 
anisotropy, and the complex geometries of head tissues, including orifices in the skull such as the 
auditory canals and the orbits. The published anatomically-accurate ECT models [122, 123] 
consider only isotropic tissue conductivity, explore only a limited set of electrode configurations 
(BL and RUL), and do not perform region of interest (ROI) analysis of the field distribution in 
the brain. The computational models of non-ECT transcranial electric stimulation offer some 
insights into the biophysics of the problem, but do not provide data specific to ECT electrode 
configurations and stimulus current parameters. 
For realistic models of the electric field generated by ECT, the inclusion of anisotropic 
conductivity of the white matter (WM) may be of particular importance since the electric field 
induced by ECT is typically widespread and reaches deep brain regions [117, 122], and since 
depression itself is associated with regionally specific abnormalities of the WM fractional 
anisotropy [141, 142]. Our and other groups have previously incorporated tissue anisotropic 
conductivity in models of electroencephalography (EEG) and magnetoencephalography (MEG) 
[73, 90, 93-95, 97, 143-147], transcranial direct current stimulation (tDCS) [127, 135, 140, 148], 
deep brain stimulation [149], transcranial magnetic stimulation (TMS) [150, 151], and electrical 
impedance tomography [152]. These studies demonstrate that anisotropic conductivity of the 
brain tissue can have a non-negligible effect on the electromagnetic field solutions. However, 
computational models of ECT have not incorporated tissue conductivity anisotropy to date.   
No direct and non-invasive in vivo measurement of brain conductivity anisotropy is 




water molecules enables estimation of the effective electrical conductivity tensors from the water 
self-diffusion tensors which can be non-invasively acquired with diffusion tensor magnetic 
resonance imaging (DT-MRI) [63, 64]. Several methods have been proposed to derive the WM 
anisotropic conductivity from the measured diffusion tensors. In the effective medium approach 
[153, 154], the WM anisotropic conductivity tensors were directly calculated by a linear scaling 
of the diffusion tensors using an empirically determined scaling factor [153-155]. However, 
Rullmann et al. [147] and Gullmar et al. [93] have pointed out that using this linear scaling 
approach may lead to extremely large anisotropic ratios in the resulting conductivity tensors. An 
alternative is the volume constraint approach where the WM anisotropic conductivity tensors are 
computed with a fixed anisotropic ratio in each WM voxel, under the assumption that the shape 
of the WM diffusion tensors is prolate (cigar-shaped), rotationally symmetric ellipsoid [90, 156]. 
With this method, the fixed anisotropic conductivity ratio of the WM tissue can be obtained from 
direct measurements, e.g., 10:1 for parallel:normal orientation relative to the nerve fibers [157]. 
Another anisotropy modeling technique is based on the linear conductivity-to-diffusivity 
relationship in combination with a constraint on the magnitude of the electrical conductivity 
tensor [94, 95]. A “volume fraction algorithm” considering the partial volume effects of the 
cerebrospinal fluid (CSF) and the intravoxel fiber crossing structure has also been suggested 
[158], but no further studies using this approach have been reported. 
In summary, existing studies of the electric field or current density resulting from ECT 
have investigated few electrode configurations in realistic-geometry head models, have not 
incorporated tissue conductivity anisotropy, and have not carried out analysis of the electric field 
strength in specific brain ROIs. Addressing these limitations, in the present study we develop an 





heterogeneity and WM anisotropic conductivity, based on individual structural MRI and DT-
MRI scans. We use the head model to simulate the electric field generated in the brain by the BL, 
BF, RUL, and FEAST ECT electrode configurations. We quantify the differences in electric field 
strength among the various ECT electrode configurations in brain ROIs that have putative role in 
the therapeutic action and/or adverse side effects of ECT. This analysis enables us, for example, 
to explore whether forms of ECT associated with fewer cognitive side effects induce lower 
electric field strengths in hippocampus, and to evaluate the degree to which frontal electrode 
configurations (BF and FEAST) achieve focal frontal stimulation. We also investigate how the 
WM conductivity anisotropy affects the electric field distribution in the brain. This study 
demonstrates the utility of anatomically-realistic computational models to provide clinically 
salient analysis and recommendations for the optimization of ECT.  
 
3.2. Materials and Methods 
We simulated the electric field strength and distribution induced by ECT in a realistic finite 
element head model using the same methods described in Chapter 2.  
 
3.2.1. ECT Finite Element Head Model Generation 
An anatomically realistic human head model was created from T1-weighted magnetic resonance 
imaging (MRI) (1×1×1 mm
3
 voxel) and diffusion tensor imaging (1.75×1.75×2 mm
3
 voxel) data 




preprocessing of the structural T1-weighted MRI images as described in Chapter 2. In this 
Chapter, for FE volume conductor modeling the T1-weighted MRI was first coregistered to the 
DT-MRI using SPM5 [76] (Wellcome Department of Cognitive Neurology, Institute of 
Neurology, University College London) in order to avoid the transformation of the diffusion 
tensors [94, 95, 150, 152]. In this process, a voxel similarity-based registration technique was 
applied to acquire coregistered T1-weighted MRI by maximizing mutual information that 
measures the degree of mutual dependence between the image intensities of corresponding 
voxels in both images [159]. To generate the FE meshes from the coregistered structural MRI 
images, the MRI images were segmented into five different sub-regions including scalp, skull, 
CSF, gray matter, and WM. BrainSuite2 [160] was used to extract brain tissue compartments 
(gray matter and WM) as well as CSF regions including the ventricles. We then segmented the 
skull and scalp regions using a skull extraction algorithm [161] based on a combination of 
thresholding and mathematical morphological operations including opening and closing.  
We next modeled three conventional electrode placements (BL, BF, and RUL) [79, 80] 
and an investigational configuration (FEAST) [81, 82] diagrammed in Figure 2.1. Standard 
round electrodes (5 cm diameter) were modeled for the BL, BF, and RUL electrode 
configurations. For BL ECT, the two electrodes were centered bilaterally at the frontotemporal 
positions located 2.5 cm above the midpoint of the line connecting the external canthus and 
tragus [80]. For BF ECT, the electrodes were placed bilaterally 5 cm above the outer angle of the 
orbit on a line parallel to the sagittal plane [79]. For RUL ECT, one electrode was centered 2.5 
cm to the right of vertex and the second electrode was placed in the homologous right 





placed over the right motor strip and a small circular electrode (2 cm diameter) was placed over 
the right eyebrow.  
Finally, we applied adaptive finite element meshing technique to the human head model 
incorporating the stimulation electrodes [88]. The resulting FE mesh of the human head and the 
ECT electrodes consists of approximately 1.6 million tetrahedral elements. 
 
3.2.2. Electrical Conductivity Assignment 
To evaluate the effect of WM anisotropy on the electric field, we simulated the electric field in a 
model with WM anisotropic conductivity as well as in a model with fully isotropic conductivity. 
In the isotropic head model, the electrical conductivities were assigned to 9.8×10
5
 S/m for the 
steel electrodes, 0.33 S/m for scalp, 0.0132 S/m for skull, 1.79 S/m for CSF, 0.33 S/m for gray 
matter, and 0.14 S/m (nominal) for WM [73, 89, 90]. In the anisotropic model, all tissues except 
WM were assumed to be isotropic, since the WM has the most significant anisotropic 
microstructure [157, 162]. Another tissue that is often treated as anisotropic is the skull [96, 115, 
135, 146, 148, 163]. However, the effective skull anisotropy originates from the macroscopic 
skull structure consisting of a soft (spongiform) bone layer enclosed by two hard (compact) bone 
layers [163, 164]. Therefore, the most accurate approach is to model the skull as three discrete 
isotropic layers [138, 165-167]. In the present study, however, we modeled the skull as a single 
isotropic layer, since the low MRI signal from bone makes accurate skull layer segmentation 
difficult [168], and since the mostly radial flow of current in the skull justifies the compound 




We estimated the WM anisotropic conductivity tensors under the assumption that the 
conductivity tensors share eigenvectors with the measured diffusion tensors [63]. We applied the 
volume constraint approach to derive the WM anisotropic conductivity with a fixed anisotropy 
ratio in each WM voxel [90]. The detailed methodology of deriving the WM anisotropic 
conductivity tensors is described in Chapter 2. In the present study, we used a fixed anisotropy 
ratio of 10:1 (k = 10) (Nicholson, 1965), yielding long = 0.65 S/m and trans = 0.065 S/m.  
To investigate how well isotropic models approximate the anisotropic model, we also 
simulated models with isotropic WM conductivity ranging from the transverse (low) 
conductivity estimate,
iso = 0.065 S/m, to the longitudinal (high) conductivity estimate, iso = 
0.65 S/m, including the nominal volume-constraint value of 
iso = 0.14 S/m. 
 
3.2.3. Electric Field Analysis 
To determine the electric field distribution and magnitude in the brain induced by each ECT 
electrode configuration, the quasi-static Laplace equation was solved using the preconditioned 
conjugate solver in ANSYS (ANSY Inc., Canonsburg, PA, USA) (for the details see Chapter 2).   
The electric field was sampled in specific brain ROIs thought to be associated with 
therapeutic action of ECT, including frontal pole, orbitofrontal cortex (OFC), dorsolateral 
prefrontal cortex (DLPFC), thalamus, hypothalamus, and subcallosal cingulate cortex (SCC) [79, 
81, 169-173], or with side effects of ECT, including hippocampus and insula [36, 174-176]. We 
also examined the electric field in primary motor cortex (specifically, the first dorsal interosseous 
(FDI) motor area) and brainstem, which are thought to be relevant to seizure initiation and motor 





manually segmented from coronal MRI sections, based on human brain atlases and definitions in 
the literature [179-186], and were verified with the BrainParser software [187]. We then 
computed descriptive statistics of the electric field strength (median, 25th and 75th percentiles, 
and minimum and maximum) in each of these ROIs as well as in the whole left and right 
hemispheres for the BL, BF, RUL, and FEAST electrode configurations.  
We assessed the effect of the WM anisotropic conductivity on the induced electric field 
qualitatively by plotting maps of the electric field magnitude and current density vectors, and 
quantitatively by calculating the relative difference in electric field magnitude between the two 
solutions in various ROIs. The difference between the isotropic and anisotropic solutions was 
quantified by the statistical measure of relative error, defined as 





















Error Relative                    (3.1) 
where n is the number of samples in the respective ROI, and isoE  and anisoE  denote the electric 
field magnitude in the isotropic and anisotropic models, respectively [71, 73, 127, 188, 189]. 
 
3.3. Results 
3.3.1. 3-D Finite Element Head Model  
The human head model used for the electric field simulation is displayed in Figure 3.1. Figure 
3.1(a) shows a cut-away 3-D rendering of the head model. The cropped section illustrates the 





Figure 3.1. 3-D finite element head model: (a) Partial volume rendering of the human head 
model. The cropped section shows the five segmented tissue compartments. (b) A transaxial 
conductivity map with the principal orientations (the largest eigenvectors) of the WM 
conductivity tensors projected as black bars onto the WM regions. (c) Enlarged view of the 
region framed in white in (b). 
matter (red), and WM (gray). Figure 3.1(b) shows a transaxial conductivity map with the 
principal orientation of the electrical conductivity tensors (corresponding to the orientation of the 
WM fibers) projected as black bars onto the WM regions. For clarity, a portion of the 
conductivity map framed in white in Figure 3.1(b) is magnified in Figure 3.1(c). 
 
3.3.2. Comparison of ECT Electrode Configurations 
Figure 3.2 shows a set of results for the spatial electric field magnitude distribution in the head 
model incorporating a fixed WM anisotropy ratio of 10:1. A qualitative comparison of the spatial 
electric field distributions in Figure 3.2 indicates that the different ECT electrode configurations 





tends to occur in the brain volume under and between the two electrodes, although the detailed 
distribution is complex and depends heavily on the head anatomy. The symmetric ECT electrode 
configurations (BL and BF) have comparable electric field strength in both hemispheres, 
whereas the lateralized configurations (RUL and FEAST) generate higher electric field 
magnitude in the right hemisphere. Similarly, configurations with anterior electrodes (BF and 
FEAST) induce stronger electric fields in the anterior portions of the brain than the other 
configurations with more posterior electrodes (BL and RUL).  
Figure 3.3 shows descriptive statistics of the electric field strength (median, 25th and 
75th percentiles, and minimum and maximum) in various ROIs in the left and right hemispheres 
of the anisotropic head model for each ECT electrode configuration. The median electric field 
strength in the whole brain is 3.9, 1.5, 2.3, and 2.6 V/cm, and the right-to-left hemisphere median 
electric field ratio is 1.0, 1.0, 2.1, and 1.9 for the BL, BF, RUL, and FEAST configurations, 
respectively. Besides generating the strongest electric field overall, BL ECT produces the highest 
median electric field in the hippocampi (4.8 V/cm), which is 1.5–2.8 times stronger than the 
hippocampal electric field of the other electrode configurations. In comparison to BL, RUL ECT 
has weaker median electric fields in all regions except in the right FDI motor area, where it is 1.4 
times stronger. The ratio of the frontal (frontal pole, OFC, and DLPFC) to temporal 
(hippocampus) median electric field is 0.9, 3.5, 0.9, and 1.7 for the BL, BF, RUL, and FEAST 
configurations, respectively. Due to its frontal electrode placement, BF ECT has the highest 
frontal-to-temporal field ratio (3.5) among the configurations, inducing the strongest electric 
field in the frontal pole as well as substantial field strength in the OFC and DLPFC. Compared to 
the BF and RUL electrode placements, FEAST produces stronger median electric field 





Figure 3.2. Cut-away 3-D rendering of the head model (top row) and the E-field magnitude 
spatial distribution in the anisotropic head model for BL, BF, RUL, and FEAST electrode 
configurations (second to bottom rows, respectively) with 800 mA current. Columns from left to 
right show axial, coronal, and sagittal views, respectively. The color map is clamped at an upper 







Figure 3.3. Descriptive statistics of the regional E-field magnitude generated by the four ECT 
electrode configurations in the left and right hemispheres of the anisotropic head model. The E-
field strength (y-axis) is shown on a logarithmic scale. The boxes indicate the interquartile range 
(25th to 75th percentile) with the median marked by a thick horizontal black line. The whiskers 
delimit the minimum and maximum of the regional E-field distribution.  
 
the other configurations, FEAST induces 1.2–2.0, 1.4–2.4, and 1.6–2.2 times stronger electric 




3.3.3. Effect of White Matter Anisotropic 
Conductivity  
To demonstrate the effect of WM anisotropy on the electric field and current density solutions, in 
Figure 3.4 we plotted maps of the electric field magnitude and the current density vector field in 
a coronal slice (same as in Figure 3(middle row)) for BL and RUL ECT in the nominal isotropic 
(WM 
iso = 0.14 S/m) and anisotropic head models. In this slice, the BL and RUL configurations 
generate, respectively, predominantly mediolateral and inferosuperior current flow. In both the 
isotropic and anisotropic models, the high conductivity of CSF-filled structures tends to channel 
current flow, as illustrated by the larger arrows in the lateral ventricles in Figures 3.4(c) and (d) 
and in the longitudinal fissure in Figures 3.4(e) and (f). Despite the higher current density in 
CSF-filled structures, the electric field magnitude there is relatively low (blue color) due to the 
high conductivity. Compared to the isotropic models (Figures 3.4(c) and (e)), in the anisotropic 
models (Figures 3.4(d) and (f)) additional channeling effects emerge as a result of the WM fiber 
orientation. For example, when the current flow is partially aligned with the orientation of the 
WM fibers, the anisotropic model enhances the current alignment with the fibers, as 
demonstrated by the curving of the current flow along the WM fibers in the corpus callosum and 
in the regions inferior to the lateral ventricles in BL ECT (Figure 3.4(d) versus Figure 3.4(c)). 
Furthermore, long stretches of fibers aligned with the current flow can result in denser current 
along the fibers, as demonstrated by the concentrated current flow along the inferosuperior-
oriented internal capsule fibers in both hemispheres in RUL ECT (Figure 3.4(f) versus Figure 
3.4(e)). On the other hand, current flowing in direction transverse to the WM fiber orientation 





the WM fibers, as exemplified by the regions well demarcated in red color in the BL electric 
field map (Figure 3.4(d) versus Figure 3.4(c)) corresponding to lateromedial current flow across 
inferosuperior and anteroposterior oriented pyramidal tract fibers. 
Quantitatively, the electric field magnitude relative error over the whole brain of the 
nominal isotropic model (WM 
iso = 0.14 S/m) compared to the anisotropic model is 18%, 7%, 
7%, and 6% for BL, BF, RUL, and FEAST ECT, respectively. Figure 3.5 breaks these data down 
for distinct ROIs in the left and right hemispheres. The largest ROI error (39%) is observed in 
the left FDI motor area for RUL ECT, and the lowest error (1%) occurs in the left frontal pole for 
BL ECT. In prefrontal and frontal areas including frontal pole, OFC, and DLPFC in Figures 
3.5(b)–(d), the maximal error of 19% occurs with RUL ECT in the left OFC. The SCC in Figure 
3.5(g) exhibits relatively large differences compared to other ROIs, ranging from 14% (FEAST) 





Figure 3.4. Comparison of the isotropic and anisotropic model simulations. (a) A coronal slice 
conductivity map using the same display conventions as in Fig. 2. (b) Enlarged view of the 
region framed in white in (a). (c–f) View corresponding to (b) of the E-field magnitude 
distribution (in color scale) and current density vector field of the isotropic (left) and anisotropic 








Figure 3.5. Relative error of the electric field magnitude in the isotropic versus the anisotropic 
head model for the various brain ROIs and ECT electrode configurations. Relative error is 





Figure 3.6 shows the relative error in electric field magnitude over the whole brain 
between the isotropic and anisotropic models as a function of the WM conductivity in the 
isotropic model. The largest errors occur with the highest isotropic conductivity of 0.65 S/m for 
all configurations. The lowest errors, indicating the “best” isotropic model match to the 
anisotropic model, are at 
iso  = 0.11 S/m for BL and BF ECT and at iso  = 0.18 S/m for RUL 
and FEAST ECT, which are close to but distinct from the volume-constraint value of 





Figure 3.6. Electric field magnitude relative error in the whole brain between the anisotropic 
head model (WM long = 0.65 S/m and trans = 0.065 S/m) and the isotropic model with WM 
conductivity ranging from 
iso = 0.065 S/m to 0.65 S/m. The four curves correspond to the four 





3.4. Discussion and Conclusions 
Even though the electric field spatial distribution is a key aspect of dosage in ECT, it has not 
been accurately characterized. The spatial distribution of the electric field strength is a 
determinant of which brain regions are directly activated by the electric stimulation delivered by 
various ECT electrode configurations. This work represents the first quantitative study 
investigating the regional differences in electric field strength resulting from variations in the 
ECT electrode configuration in an anatomically realistic head model. 
 
3.4.1. Implications for ECT Technique 
It has been suggested that the flow of electric current and a resultant robust seizure expression in 
the prefrontal cortex is requisite to the antidepressant effects of ECT, as demonstrated, for 
example, by the superior efficacy of BL ECT compared to low dose RUL ECT [81, 169, 190]. 
This view has motivated electrode configurations designed to target the prefrontal cortex, such as 
BF and FEAST. The results from our model confirm that BL ECT generates stronger electric 
field in anterior portions of the brain compared to RUL ECT. Our results further indicate that BF 
and FEAST generally produce higher electric field strengths in prefrontal structures compared to 
BL and RUL ECT (see Figures 3.2 and 3.3). In particular, compared to the other electrode 
configurations, BF produces the highest electric field magnitude in the frontal poles. 
Furthermore, FEAST produces the strongest electric field in the right OFC, DLPFC, and SCC—
likely a consequence of current flow through the orbits which represent low impedance paths 




with reported antidepressant efficacy. The right DLPFC has been targeted with low-frequency 
(inhibitory) repetitive TMS for the treatment of depression [191]. There is evidence that focal 
stimulation of the SCC via deep brain stimulation reduces elevated SCC activity and normalizes 
aberrant network activity in depression, with resultant antidepressant effect [173, 192]. The 
frontal pole and OFC have strong anatomical and functional connectivity with the SCC and the 
rest of the dysfunctional brain network associated with depression [173, 193-195] and therefore 
are potential targets for stimulation as well.  
Another prevailing hypothesis on the mechanism of action of ECT focuses on 
diencephalic stimulation. This hypothesis states that for optimal antidepressant efficacy, the 
seizure must be sufficiently generalized to involve diencephalon centers, particularly the 
thalamus and hypothalamus [79, 169]. Cortical–thalamocortical interactions are crucial for the 
initiation, propagation, and behavioral manifestations of generalized seizures [196, 197]. 
Thalamic processes that inhibit cortical function have been hypothesized to play a role in the 
antidepressant effect of ECT [170, 197-199]. Our results show that BL ECT produces stronger 
electric field in the thalamus and hypothalamus compared to BF and RUL ECT, consistent with 
the superior antidepressant efficacy of BL ECT as compared with low dose RUL ECT, but does 
not explain how adequately-dosed RUL ECT matches the efficacy of BL ECT. Notably, FEAST 
produces electric field strengths in the diencephalon centers that are higher than in BF and RUL, 
and approach those in BL. However, whether this confers high antidepressant efficacy to FEAST 
is unknown since FEAST clinical data has not been reported. 
It has been suggested that retrograde amnesia may be related to seizure activity in the 
medial temporal lobe [175, 200, 201] and consequently it was proposed that techniques inducing 





medial temporal structure specifically associated with amnesia is the hippocampus, which has 
been shown to be uniquely affected by induced seizures, and to have a low seizure threshold 
[175]. Of all configurations in our model, BL ECT produces the strongest electric field in the 
hippocampi, consistent with its greater acute cognitive impairment [36, 174] and short- and long-
term retrograde amnesia [175, 176] compared to BF and RUL ECT. Our results may be 
particularly useful for predicting the clinical effects of ECT paradigms for which clinical data is 
not yet available, such as FEAST. For example, the electric field strength generated by FEAST is 
lower than RUL in the right hippocampus, but is higher than RUL in the left hippocampus, and is 
higher compared to BF in both hippocampi. Therefore, one might predict that FEAST may have 
memory side effects lower than in BL but higher than in BF (assuming identical current levels in 
all configurations); this is yet to be tested clinically. 
The electric field model could also inform the mechanisms behind cardiac effects of 
ECT. Accumulating evidence indicates that cardiovascular regulation receives significant input 
from cortical structures, especially the insula [202]. Direct electrical stimulation of the left 
caudal anterior insula leads to increased occurrence of bradycardia and depressor responses as a 
result of parasympathetic activation, whereas right anterior insular stimulation leads to 
tachycardia and diastolic blood pressure elevation as a result of sympathetic activation [203, 
204]. Data from patients with insular lesions are consistent with left insular cardioinhibitory 
representation and right insular cardioexcitatory representation [203]. During the stimulus 
delivery phase of ECT, a higher likelihood of heart rate reduction and longer duration of asystole 
were observed with RUL compared to BL and BF ECT [205]. Since RUL ECT produces nearly 
three times higher electric field strength in the right insula compared to the left insula (Figure 




compared to the left insula, resulting in sympathetic withdrawal. In contrast, BL and BF ECT 
induce similar electric field strengths in left and right insula, thus the sympathovagal balance is 
less affected, consistent with the lower rates of asystole observed clinically [206, 207]. Other 
brain regions, such as the hypothalamus and brainstem, are also known to be involved in cardiac 
regulation [208]; therefore, the electric field characteristics in these regions (Figures 3.3(f) and 
(k)) may also contribute to cardiac effects. 
Our results indicate that the electric field strengths induced by RUL are exclusively 
weaker than in BL ECT except in the right motor strip where the electric field magnitude 
induced by RUL ECT is about 38% stronger compared to BL. This observation is consistent with 
the lower seizure threshold of RUL compared to BL ECT, since the motor strip is thought be the 
likely site for seizure initiation [178]. We also found that BL and FEAST generate higher electric 
field strengths compared to BF and RUL in the brainstem which mediates the motor 
manifestations of generalized tonic-clonic seizures [177].  
The above observations illustrate how the realistic ECT electric field model can 
contribute to a biophysical explanation of reported clinical differences among conventional 
electrode placements (BL, BF, and RUL), as well as to the evaluation and optimization of 
investigational configurations (e.g., FEAST). For example, the realistic head model can be 
coupled with an optimization algorithm to select scalp electrode locations and current strengths 
to target specific brain structures [209, 210]. Ultimately, this work may guide the development of 







3.4.2. Influence of Tissue Conductivity Anisotropy 
The second objective of this study was to evaluate the influence of WM conductivity anisotropy 
on the electric field simulation. Our results, summarized in Figures 3.4 and 3.5, indicate that 
neglecting WM conductivity anisotropy and using instead the volume-constraint WM isotropic 
conductivity value of 0.14 S/m leads to relative errors in the electric field magnitude up to 18% 
for the whole brain and up to 39% within the considered ROIs. The maximum relative error was 
found in the left FDI motor area for RUL ECT. In addition, our results indicate that the electric 
field differences between the isotropic and anisotropic models depend upon the specific ECT 
electrode configuration used. For example, ignoring WM anisotropy produces errors in the FDI 
motor area electric field up to only 8% for the BF configuration, but up to 39% for the RUL 
configuration. Furthermore, the WM isotropic conductivity value that gives the best 
approximation of the anisotropic case, in terms of the lowest overall relative error, varies with 
electrode configuration, as shown in Figure 3.6. Specifically, the optimal WM isotropic 
conductivity value for the lateralized configurations (0.18 S/m for RUL and FEAST) is 64% 
higher than that for the bilaterally symmetric configurations (0.11 S/m for BL and BF). A 
possible explanation for this difference is that in the lateralized electrode configurations the 
electrical current is more aligned, on average, with the orientation of the WM fibers than in the 
bilaterally symmetric configurations. The results in Figure 3.6 also indicate that the volume-
constraint WM isotropic conductivity (0.14 S/m) yields relative errors within 0.7% of the optima 
achievable with the isotropic models and is, therefore, a reasonable choice for isotropic models. 
Generally, the electric field magnitude errors and their sensitivity to the electrode configuration 
motivate the inclusion of the WM conductivity anisotropy in computational electric field models 




Another important observation is that the error in the electric field strength between the 
isotropic and anisotropic models usually increases for brain regions that are farther away from 
the ECT electrodes. For example, the electric field errors in deep brain structures such as 
thalamus, hypothalamus, insula, and SCC (10%–39%) are higher than the errors in more 
superficial areas such as frontal pole and DLPFC (1%–12%) which lie closer to the scalp 
electrodes. Furthermore, although the overall relative error in the whole brain is higher for BL 
than for BF, the relative error is larger for BF than for BL in ROIs such as hypothalamus, 
hippocampus, insula, and brainstem that are farther away from the BF electrodes. Similarly, in 
the lateralized electrode configurations (RUL and FEAST), the electric field errors for highly 
lateralized ROIs (whole hemisphere, DLPFC, insula, and FDI motor area) are significantly larger 
on the left side than on the right side (where the electrodes are placed). The electric field error 
increase away from the electrodes could be explained in terms of the longer paths that the 
electrical current has to traverse from the electrodes to distant brain regions, which results in a 
larger cumulative error of all the differences in the conductivity tensors along the current path. 
Thus, incorporation of WM conductivity anisotropy in ECT electric field models is crucial for 
analysis of the electric field characteristics in brain regions that we try to avoid stimulating by 
placing the electrodes away from them. Often these are brain regions thought to be associated 
with adverse side effects of ECT, and thus the degree to which they are stimulated is of particular 
relevance to studies that evaluate ECT techniques aimed at improving safety. This observation 
further supports the inclusion of WM anisotropic conductivity in ECT models. 
The comparison of the isotropic and anisotropic model simulations in Figure 3.4 provides 
insight into how the orientation of WM fibers affects the current density and electric field 





Consequently, compared to the isotropic model, current flow along the WM fibers in the 
anisotropic model is denser and follows the fiber orientation. In some cases the channeling of 
current along WM fiber tracts increases the local electric field strength, but in other cases this 
effect is offset by the lower impedance along the fibers, leading to reduced electric field strength. 
The current may steer away from segments of increased impedance resulting from the passage of 
WM fibers perpendicular to the current flow. However, when current comes across wide 
stretches of fibers perpendicular to its flow, the current cannot steer away and is forced to cross 
this high impedance barrier, resulting in high electric field magnitude. Thus, increased electric 
field strength in the anisotropic model compared to the isotropic model can result from either 
concentration of current flow along WM fibers that is not offset by the low impedance along the 
fibers, or from increased impedance for current flow perpendicular to WM fibers. 
In support of our findings, other bioelectric head modeling studies have reported 
comparable effect sizes associated with the inclusion of WM conductivity anisotropy. We 
previously studied the impact of WM anisotropy on the current density distribution generated by 
tDCS and found relative errors of 53% and 19% in current density magnitude in the WM and 
gray matter, respectively [127]. Similarly, Sadleir et al. [91] concluded that the inclusion of the 
WM anisotropic conductivity in a tDCS model would result in differences up to 39% in the 
median current density magnitude. De Lucia et al. [150] found that WM anisotropy contributes a 
difference of 10% in the peak TMS-induced electric field, which is consistent with the findings 
of Thielscher et al. [151]. (It should be noted that the TMS electric field is substantially more 
superficial than the electric field in ECT and tDCS; therefore, the lower error associated with 
WM anisotropic conductivity in TMS is expected). Finally, Wolters et al. [90] reported that the 




electroencephalographic scalp potentials generated by dipole sources within the brain. Thus, the 
differences between the isotropic and anisotropic model results in these studies are comparable 
to the relative errors up to 39% found in our study.  
It has been reported that depression itself is associated with changes in the volume of 
specific brain structures [211, 212] and with regionally specific abnormalities of the WM 
fractional anisotropy [141, 142]. Patients with major depressive disorder showed a fractional 
anisotropy reduction up to 14% in WM, with an 8% decrease in the superior longitudinal 
fasciculus associated with the DLPFC [141]. Neglecting WM anisotropy in our model, which is 
associated with fractional anisotropy reduction of 100%, results in up to 39% difference in 
electric field strength. Extrapolating from these data, a pathological 14% decrease in fractional 
anisotropy could result in approximately 6% difference in the electric field strength. Even though 
this effect is relatively small, tissue conductivity anisotropy and other pathological brain 
structure changes should be considered as a potential source of electric field variability, as their 
compounded effect may be significant. 
 
3.4.3. Model Validity and Limitations 
Validation of brain stimulation electric field simulations remains a challenging problem due to 
the unavailability of methods for high-resolution in vivo electric field measurements. 
Nevertheless, our results in the brain (electric field strength median of 1.5–3.9 V/cm and range of 
0.1–300 V/cm) are in good agreement with published modeling and experimental measurements. 
In the references to other studies below, the electrode current was scaled to 800 mA to allow 





Nadeem et al. [122] did not report statistics on the electric field distribution, but the figures 
suggest a brain electric field magnitude ranging from approximately 0.1 V/cm to as high as 700 
V/cm. Rescaling the current from Sadleir et al.’s [91] and Parazzini et al.’s [131] anatomically-
realistic tDCS models and converting current density to electric field strength, the average of 
their reported median values is 2.5 V/cm and 2.7 V/cm, respectively. Studies using simplified 
model geometries or low-resolution experimental measurement techniques generally reported 
lower electric field strengths [113-115, 117]. For instance, a recent simulation study by our 
group of BL, BF, RUL, and FEAST ECT in a spherical head model obtained median and 
maximum brain electric field strength ranges of 0.6–1.2 V/cm and 2.1–2.5 V/cm, respectively 
[117]. Rush and Driscoll’s [115] measurements of a frontal-occipital electrode configuration in a 
half-skull immersed in an electrolytic tank yielded maximum electric field in the range of 1.5–
2.5 V/cm. Intracerebral measurements in cadaver heads with stimulation current applied through 
bifrontotemporal electrodes produced maximum electric field strength estimates of 0.7–1.8 V/cm 
[113, 114]. A likely factor contributing to the lower electric field strengths reported in these 
studies is the effective averaging out of the spatial distribution of the electric field resulting from 
the simplified head models and/or from the low-resolution spatial sampling of the electric 
potentials in the cadaver measurements. Indeed, a study comparing head models for TMS found 
a ~ 51% increase of the maximum electric field strength in the anatomically-realistic model 
compared to simplified spherical models [151]. 
A limitation of the present study that may impact the electric field strength and 
distribution is the truncation of the head model. The T1-weighted MRI data was only acquired 
for the portion of the head above the level of the auditory canal. The truncated head model 




increased electric field magnitude in the brain. Further, the head model truncation has differential 
effects for various ECT electrode placements. For example, in our ECT analysis using a 
spherical head model (data not shown), we observed that truncation of the head model results in 
a 52% and 27% increase in the median electric field and a 41% and 14% increase in the peak 
electric field for BL and RUL ECT, respectively. Therefore, future ECT head models should be 
based on structural MRI and DT-MRI data set of the whole head including the skull base and a 
portion of the neck underneath.   
Uncertainty about the thickness, structure, and conductivity of the various tissues in the 
model can contribute to inaccuracies of the simulated electric field and to discrepancies among 
various models and experimental measurements [213], but it is difficult to assess the extent of 
these uncertainties since, as discussed in the beginning of this section, there are no adequate 
empirical data to compare simulations to. For example, we observed overall comparable electric 
field strength in the left and right hemispheres for the symmetric ECT electrode configurations 
(BL and BF). However, certain regions such as hypothalamus, SCC, and FDI motor area 
produced asymmetric results of the median electric field magnitude (see Figure 3.3). This may be 
due to intrinsic anatomical asymmetry and/or errors in the tissue segmentation and the ROI 
boundary definition between the two sides of the head, but it is difficult to determine how much 
each of these factors is contributing.  
There are two distinct sources of uncertainty that confound the conclusions of modeling 
studies: first, naturally occurring anatomical variability in the population and, second, errors in 
the tissue segmentation and tissue conductivity within the modeled individual(s). We have 
previously investigated the effect on the induced electric field in a spherical head model of 





literature [45]. That study reported that, for example, individual male scalp and skull thickness 
variation, which can be as high as 58% and 34% of the average, resulted in up to 76% and 20% 
changes of the peak brain electric field, respectively [45]. The present study does not account for 
anatomical variability in the population since it is based on imaging data of a single individual; 
this limitation has to be considered when applying these results to interpret clinical ECT data 
obtained from various individuals. Nevertheless, the methods presented in this paper are general 
and can be applied to any individual with appropriate MRI data. 
The second source of uncertainty is modeling errors of the tissue structure and electrical 
properties within an individual model. For example, the average thickness of the scalp, skull, and 
CSF underlying the skull are about 5.5 mm, 7 mm, and 3 mm, respectively [45], and the T1-
weighted structural MRI data used to create our model has spatial resolution of 1 mm. Therefore, 
the MRI resolution contributes potential error of approximately 18%, 14%, and 33% to the 
thickness of the scalp, skull, and CSF, corresponding to estimated errors in the peak brain 
electric field up to 24%, 11%, and 14%, respectively, based on our perturbation data in the 
spherical male head model [45]. Further, even though a single skull layer is a reasonable choice 
for spherical models, the nonuniformity of the compact and spongiform layers in a real skull 
motivates the segmentation of these layers in a high-accuracy model [166], which may require 
coregistering the MRI scan with a computed tomography scan that provides substantially 
stronger signal from bone [168]. There is also a wide spread of tissue conductivity values 
reported in the literature, especially for the skull [116], and it is not known how much of this 
variability is attributable to individual variation and how much—to measurement error. For 
example, in this study we used skull conductivity value of 0.0132 S/m whereas other studies 




model with the lower skull conductivity of 0.0083 S/m (data not shown), the nominal model with 
skull conductivity of 0.0132 S/m increases the median electric field magnitude in the brain by 
13%, 10%, 16%, and 16% for BL, BF, RUL, and FEAST ECT, respectively. These estimates of 
electric field variability due to potential tissue thickness and conductivity errors are 
commensurate with the electric field relative errors up to 18% overall and up to 39% in specific 
ROIs that result from neglecting WM anisotropy in the present study. Therefore, it could be 
argued that accounting for WM anisotropy is as important to electric field strength estimation as 
accurate tissue segmentation and conductivity assignment. Beyond that, anisotropic models may 
give more accurate electric field directionality information, as suggested by Figure 3.4, which 
may be particularly relevant if the electric field data were coupled with neural models which are 
direction sensitive [214, 215]. 
In our anisotropic volume conductor modeling, we adopted the volume constraint 
algorithm to estimate the WM anisotropic conductivity tensors with the assumption of a fixed 
anisotropy ratio of 10:1 in each WM voxel [90]. However, this approach may overestimate the 
actual ratio of the WM anisotropic conductivity tensors [94, 95]. In reality, the ratio of 
longitudinal to transverse WM conductivity varies. For example, the fractional anisotropy map 
shown in Figure 2.1 (Chapter 2) indicates that strong anisotropy is present in the pyramidal tracts 
and corpus callosum. On the other hand, cortical brain regions include lower degree of WM 
anisotropy, which is associated with lower anisotropic conductivity ratios. Recently, Bangera et 
al. [216] conducted an experimental validation of anisotropic head models by measuring 
intracranial electric potentials generated by stimulation with an implanted dipole source in the 
human brain [216]. Two different anisotropic models using, respectively, the effective medium 





were compared revealing that the former results in a better fit to the experimental data than the 
latter. In the present study, we did not examine alternative approaches for estimating the 
anisotropic conductivity tensors such as the effective medium approach [153, 154] and its 
constrained version [94, 95]. Our model allows a relatively uncomplicated incorporation of 
various anisotropy estimation approaches which could be investigated in future studies.  
It should be also acknowledged that the present simulations address only the electric field 
distribution and not the direct neural activation and the resultant seizure, the topography of 
which is also considered to be a major contributor to clinical outcome. At present there are no 
computational models that can realistically simulate the induction and propagation of seizures 
throughout the whole brain. Because we cannot realistically simulate the neural response to ECT, 
we did not explore the effect of various parameters of the ECT stimulus current such as the 
current amplitude, pulse width, and frequency. Nevertheless, since the electric field strength is 
directly proportional to the stimulus current amplitude, our data can be straightforwardly scaled 
to other current intensities. Furthermore, systematic data on the clinical effects of various current 
amplitudes is presently lacking as ECT is done exclusively with fixed current amplitudes of 800 
mA or 900 mA [111]. We have previously used the assumption of a single neural activation 
threshold throughout the brain to explore the effect of the stimulus current amplitude on the 
focality of direct neural activation in a spherical head model, and have suggested that reduction 
and individualization of the current may be productive strategies for better targeting of ECT 
[111, 117, 217]. However, more empirical data linking the electric field characteristics to seizure 
induction have to be accumulated to support the incorporation of neural dynamics in the realistic 








Chapter 4  
Electric Field Characteristics of  
ECT and MST 
4.1. Introduction 
Electroconvulsive therapy (ECT) has unparalleled antidepressant efficacy in the treatment of 
severe major depression [79]. ECT induces a generalized seizure under anesthesia for therapeutic 
purposes using electric current delivered through electrodes placed on the scalp. However, 
cognitive side effects of ECT such as retrograde amnesia limit its clinical use [20]. Variations in 
ECT technique have been introduced in an attempt to improve the risk to benefit ratio of ECT by 
manipulating stimulation parameters including electrode placement and stimulus current 
parameters [218]. For instance, high dose right unilateral (RUL) ECT has a comparable efficacy 
to bilateral (BL) ECT with a significant decrease in amnesia [38]. Alternative approaches have 
included bifrontal (BF) ECT [219] and two experimental electrode configurations, focal 
electrically administered seizure therapy (FEAST) [220] and frontomedial (FM) ECT [221], to 
target prefrontal cortex while sparing certain brain regions (e.g., hippocampus) thought to be 





(MST) which is a means to achieve more focal seizure induction using repetitive transcrnaial 
magnetic stimulation (rTMS) [1, 222]. 
Previously, using a spherical head model, we compared the suprathreshold direct 
stimulation strength and volume (focality) of ECT and MST configurations [86], showing that 
the electric field strength relative to threshold for MST is 3–6 times weaker and 10–60 times 
more focal compared with conventional ECT with 800 mA, 0.3 ms pulses. Spherical head 
models, however, are limited by the substantial simplification of the head anatomy and 
anisotropic tissue properties. In Chapter 3, in a realistic head model we quantified the induced 
electric field strength in various brain regions of interest (ROIs) by the BL, RUL, BF, and 
FEAST ECT electrode configurations [55]. However, that study used a truncated human head 
model and the electric field characteristics of FM ECT and MST have not been investigated 
directly.  
In this Chapter, we investigate the characteristics of the electric field induced in the brain 
by ECT and MST. We create an anatomically realistic finite element model of the whole head to 
simulate the electric field distribution induced by various ECT electrode and MST coil 
configurations. We determine the stimulation strength and focality relative to an estimated neural 
activation threshold to compare the electric field characteristics generated by ECT to those by 
MST. The comparison of the electric field stimulation strength and focality of various ECT and 
MST modalities could help the interpretation of clinical ECT and MST studies and may guide 







4.2. Materials and Methods 
We simulated the electric field induced by ECT and MST in a realistic human head model. The 
modeling methods are described in detail in Chapter 2 and summarized here.  
 
4.2.1. ECT and MST Head Model Generation 
One healthy human subject (male, age=34 years) participated in this study. T1-weighted 
magnetic resonance imaging (MRI) and diffusion-tensor imaging (DTI) of this subject,  
including the skull base and a portion of the neck underneath, were acquired on a 3 T Philips 
Achieva scanner (Philips Medical Systems, Best, Netherlands) using an 8-channel head coil. The 
electric field induced by five ECT electrode configurations including bifrontotemporal (BL), 
bifrontal (BF), right unilateral (RUL), and investigational anterior–posterior focal electrically 
administered seizure therapy (FEAST) and frontomedial (FM) electrode configurations as well 
as an MST coil configuration (circular) was computed in an anatomically realistic finite element 
model of the human head. All tissue regions were considered electrically isotropic except the 
white matter. We used electrical conductivity values given in Table 2.1  for the isotropic tissue 
compartments. We deployed the volume normalized technique to derive the white matter 
conductivity tensors (for details see Chapter 2).  
 
4.2.2. Electric Field Simulation 
The methods to simulate the electric field strength induced by ECT and MST are described in 





MST are relatively low (<10 kHz), the electric field solutions were obtained by deploying the 
quasi-static approximation using the finite element analysis software ANSYS (ANSYS Inc., 
Canonsburg, PA, USA). The spatial distribution of the electric field induced by each of the five 
ECT electrode configurations was computed at a current of 800 mA using the preconditioned 
conjugate gradient solver. A time-harmonic simulation with appropriate boundary conditions 
was performed to compute the spatial electric field distribution generated by CIRC MST at 
maximum output of the Magstim Theta device [86, 223]. 
 
4.2.3. Stimulation Strength and Focality Analysis 
In addition to the electric field magnitude, other factors affecting neural response include pulse 
shape, pulse width, and direction, as well as the neuronal morphology and membrane properties, 
and the state of the neuron and the neural network connected to it, which could be affected by 
anesthesia. We calibrated the electric field simulation to an empirically-derived neural activation 
threshold, Eth, by normalizing the electric field spatial distribution to that threshold, E(r)/Eth. 
Neurons in brain areas where E(r)/Eth > 1 are likely to be robustly depolarized and generate 
action potentials, whereas regions where E(r)/Eth < 1 are unlikely to produce a strong response. 
Such calibration of the electric field simulation to an empirically determined neural response 
threshold can largely take into account the various factors affecting the neural response listed 
above, and can partially compensate for inaccuracies in the tissue property modeling, since the 
neurons respond to the real electric field in the brain. For example, if frequency dispersion 




compared to the stimulus pulse shape [85, 102] and/or if the assumed tissue conductivity is 
inaccurate, these effects will be factored in Eth.  
We simulated the electric field strength for current amplitude of 800 mA for BL, RUL, 
and BF ECT (conventional in clinical practice); 612 mA for FEAST (average current amplitude 
in [220]); and 500 mA for FM ECT (as used in  [221]). MST was simulated for maximum 
current amplitude of a Magstim Theta device (as used in clinical studies) [1, 86]. 
 We calculated the stimulation strength relative to a neural activation threshold by 
dividing the electric field magnitude in the brain by the electric field threshold, E/Eth [61, 62, 
86]. We used estimates of the electric field thresholds for ECT and MST derived in our previous 
study: 0.25 V/cm for ultrabrief ECT (rectangular pulse width=0.3 ms) and 0.64 V/cm for CIRC 
MST (cosine pulse duration=0.4 ms), respectively [86]. We quantified the focality of stimulation 
by calculating the brain volume exposed to electric field magnitude stronger than the neural 
activation threshold, i.e., the volume where E/Eth ≥ 1 [61, 62, 86].  
 
4.3. Results 
4.3.1. Individual Realistic Head Model 
An individual human head model used for the ECT and MST electric field simulation is 
displayed in Figure 4.1. The segmented tissue regions corresponding to skin, skull compact, 
muscle, sclera, vertebrae, gray matter, lens, eyeball, optic nerve, white matter, and spinal cord 







Figure 4.1. An individual realistic head model of the human subject. The various conductivity 
compartments are labeled including (a) skin, (b) skull compacta, (c), muscle, (d) sclera, (e) 
vertebrae, (f) gray matter, (g) lens, (h) eyeball, (i) optic nerve, (j) white matter, and (k) spinal 
cord.  
 
4.3.2. Electric Field Distribution Relative to Neural 
Activation Threshold 
Figure 4.2 shows the simulated BL, BF, RUL, FEAST, and FM ECT electrode configurations as 
well as the CIRC MST coil configuration, and corresponding cortical surface maps as well as 
coronal cross-sectional maps of the electric field distributions relative to the neural activation 
threshold Eth at current of 800 mA for the BL, BF, and RUL ECT, 612 mA for FEAST, 500 mA 






Figure 4.2.  Simulation models of BL, BF, RUL, FEAST, and FM ECT as well as CIRC MST 
(left column). Electric field stimulation strength relative to neural activation threshold (Eth) at 
current of 800 mA for BL, BF, and RUL ECT, 612 mA for FEAST, 500 mA for FM ECT, and 
100% Magstim Theta output for CIRC MST coil configuration on the cortical surface (middle 
column) and in a representative coronal slice (right column). Eth is 0.25 V/cm for ECT and 0.64 






4.3.3. Stimulation Strength and Focality  
Figure 4.3(a) shows descriptive statistics on the electric field magnitude relative to the neural 
activation threshold in the whole brain at current of 800 mA current for the BL, BF, and RUL 
ECT, 612 mA for FEAST, 500 mA for FM ECT, and 100% stimulator output for the CIRC MST 
coil configuration. The results indicate that the stimulation strength of ECT relative to the neural 
activation threshold is substantially higher than that of MST. The median ECT induced electric 
field strength ranges from 0.8 to 3.4 times threshold, corresponding to FM and BL ECT, 
respectively, whereas for CIRC MST it is only 0.3 times threshold (0.07 V/cm). Furthermore, the 
maximum electric field strength relative to threshold induced by ECT is 1.2–7.3 times higher 
than that by MST. The percentage of brain volume stimulated above electric field threshold for 
neural activation is shown in Figure 4.3(b). Among the ECT paradigms, BL at 800 mA 
stimulates the largest brain volume (99.8%), while FM at 500 mA produces the most focal brain 
stimulation (47 %). CIRC MST produces more focal stimulation (21%) than all of the ECT 
modalities. Thus, the stimulation by MST is 3–11 times weaker (in median value) and 2–5 times 
more focal than the ECT paradigms.   
Figure 4.4(a) shows the 3-D masks of subcortical structures including thalamus, 
hippocampus, and insula. Figures 4.4(b) and (c) show the left and right hippocampal regions 
onto a transaxial MRI slice and corresponding 3-D surface renderings of left and right 
hippocampal regions, respectively.  
Figure 4.5 shows descriptive statistics on the electric field magnitude relative to the 
neural activation threshold in the left and right hippocampal regions for the various ECT and 
MST modalities. As observed in Figure 4.3(a), the stimulation strength of ECT relative to the 




median ECT induced electric field strength in hippocampus ranges from 0.9 to 3.8 times 
threshold, corresponding to FM and BL ECT, respectively, while for CIRC MST it is only 0.2 
times threshold (0.12 V/cm). Thus, the stimulation strength in hippocampus by MST is 5–20 




Figure 4.3. (a) Descriptive statistics of E-field magnitude relative to neural activation threshold 
at current of 800 mA for BL, BF, and RUL ECT, 612 mA for FEAST, 500 mA for FM ECT, and 
100% stimulator output for CIRC MST coil configuration. Boxes indicate the interquartile range 
(25th to 75th percentile) with the median marked by a horizontal black line. Whiskers delimit 
approximately the 99.3 percentile of the E-field distribution. Outliers beyond this range are 








Figure 4.4. (a) 3-D segmentation masks of subcortical structures representing thalamus, 
hippocampus, and insula. (b) Hippocampal regions onto a transaxial MRI slice and (c) 
corresponding surface renderings of hippocampus.  
 
 
Figure 4.5. Descriptive statistics of electric field magnitude relative to neural activation 
threshold in hippocampus at current of 800 mA for BL, BF, and RUL ECT, 612 mA for FEAST, 
500 mA for FM ECT, and 100% stimulator output for CIRC MST coil configuration. Boxes 
indicate the interquartile range (25th to 75th percentile) with the median marked by a horizontal 
black line. Whiskers delimit approximately the 99.3 percentile of the E-field distribution. 





4.4.  Discussion and Conclusions 
We examined the electric field stimulation strength and focality of various ECT electrode and 
MST coil configurations using a high-resolution, anatomically accurate, finite element model of 
a whole human head. The results in Figure 4.2 demonstrate the different patterns of stimulation 
in the brain for the various ECT electrode and MST coil configurations. The substantially 
different electric field exposure of the brain suggests that seizure initiation and modulation by the 
stimulus train may have different spatial profiles across the various modalities.  
Consistent with our previous findings [10], this study indicate that at the high current 
amplitude (800 mA) used in clinical ECT practice, the electric field in the brain exceeds the 
threshold for neural activation by more than 2-fold and stimulates more than 94% of the brain 
volume, much higher than necessary for seizure induction and possibly contributing to adverse 
side effects of ECT. While experimental modalities like FEAST and FM ECT produce more 
focal and closer to threshold stimulation by virtue of the electrode configuration and lower 
current amplitude, these modalities still stimulate directly more than 47% of the brain. On the 
other hand, CIRC MST induces the weakest, most superficial electric field, stimulating only 21% 
of the brain volume. Thus, MST produces very focal stimulation, that is nevertheless capable of 
inducing generalized seizures [8]. 
At conventional current amplitude of 800 mA, all standard ECT electrode configurations 
result in direct stimulation of hippocampus. BL and RUL ECT electrode configurations generate 
the strongest and weakest hippocampal electric field, respectively. The results demonstrate that 
direct hippocampal stimulation can be avoided by reducing stimulus current 2–4 fold. Of the 
evaluated ECT electrode configurations, the novel FM configuration with lower current 





CIRC MST produces the weakest hippocampal stimulation compared to the various ECT 
modalities. 
Taken together, these observations support exploring ECT paradigms with current 
amplitude lower than the minimum of conventional ECT devices (500 mA) as a means of 
reducing side effects. Reduced stimulus current may decrease side effects, but may also 
compromise therapeutic efficacy. Our study further demonstrates the utility of computational 
electric field models to examine and compare various stimulus delivery paradigms for electric 
and magnetic seizure therapy, including novel electrode/coil and current amplitude 











Effect of Anatomical Variation on 
Individual Transcranial Electric 
Stimulation Threshold 
5.1. Introduction 
Electroconvulsive therapy (ECT) is a therapeutic intervention that induces a generalized seizure 
in anesthetized patients by administering electric current to the brain via scalp electrodes. ECT is 
a highly effective treatment for medication-resistant psychiatric disorders such as major 
depression, however its use is limited by cognitive side effects [25]. The tolerability of ECT can 
be improved by using right unilateral (RUL) versus bifrontotemporal electrode configuration 
[112] as well as briefer current pulses [28, 224], both of which make the electric field induced in 
the brain more focal [111]. The current amplitude is another parameter that controls the electric 
field focality and therefore could potentially be used to make the stimulation more focal and to 





Motor threshold (MT) is the threshold pulse amplitude required to elicit a muscle twitch. 
It is commonly used in transcranial magnetic stimulation (TMS) to individualize the amplitude 
of stimulus trains in repetitive TMS paradigms and to select frequency and train duration to 
reduce the risk of inadvertent seizure [225], since it captures the effect of anatomical variability 
on the electric field induced in the brain as well as individual variation in neural excitability. 
Similarly, the MT can be determined with transcranial electric stimulation (TES) delivered 
through the electrodes used for ECT [226]. TES in an awake subject can be uncomfortable, but 
ECT-titrated MT could readily be determined in subjects under anesthesia immediately prior to 
seizure induction [226].   
If the MT data is coupled with a model of the electric field induced in the brain, the 
threshold electric field strength for neural activation can be estimated [227]. The electric field 
strength induced by TES in the brain can be simulated by computational models, ranging from 
concentric spheres [116, 117] to realistic head representation [68, 228] using the finite element 
method (FEM). Since the electric field distribution is strongly affected by individually variable 
head geometries, a realistic, individual head model provides more accurate predictions of the 
electric field induced in the brain compared to the simplified spherical models. The stimulus 
current corresponding to individual MT can be injected into the model, resulting in electric field 
strength in the motor cortex controlling the target muscle that corresponds to the neural 
activation threshold. Previously we introduced an electric field simulation model incorporating a 
waveform-specific neural activation threshold [86], however that study is limited by the five-
layer concentric spherical model and neural activation threshold estimated from studies done 




Due to the physiological and behavioral similarities between human and nonhuman 
primate (NHP), the NHP models are invaluable for understanding the mechanisms of therapeutic 
interventions [82, 229]. The NHP models can then be used to empirically estimate the neural 
activation threshold and to address clinically salient question about the rational dosing for 
seizure therapy [82]. Such NHP models have been widely used to optimize stimulation 
parameters for efficient seizure induction [226], characterize cognitive side effects of ECT [229], 
and study underlying mechanisms of action of ECT [230]. The growing use of the NHP models 
has generated strong interest in developing a realistic NHP head model based on structural 
magnetic resonance imaging (MRI) data. In generating an anatomically-accurate NHP model, 
one critical requirement is tissue segmentation of the head to represent complicated geometries 
and material properties of the head tissues. However, several challenges exist for the 
segmentation of the NHP head. There are a plethora of available segmentation tools to extract 
different tissue compartments from the human MRI images, but the existing software packages 
have been developed and fine-tuned for the human brain MRI data. As such, such tools still need 
to be adapted and optimized for the NHP brains. Furthermore, since the NHPs have relatively 
smaller brain sizes and somewhat different brain anatomy than humans, the segmentation tools 
developed for human brain MRI are not well adapted for processing the NHP MR images.  
The spatial distribution of the electric field resulting from subject-specific NHP 
computational models for TES has not been accurately characterized. An accurate estimate of the 
electric field distribution based on an individual realistic-geometry head is needed, since in vivo 
electric field measurements with high spatial resolution are currently not feasible. At present, the 
electric field or current density fields are best estimated using computational forward models [68, 





attempts have been recently made to validate the accuracy of the FEM forward models of the 
human by comparing to neurophysiological measurements [232, 233]. For instance, the 
simulated electric field strength by TMS was compared to the MEP amplitudes in response to 
single pulse TMS, revealing that the electric field magnitudes resulting from subject-specific 
models correlated with physiologically observed MEP amplitudes [233]. Scalp surface potentials 
generated by the FEM simulation of TES were correlated with induced scalp voltages by low-
intensity TES [232]. In fact, a substantial number of electric field/current density modeling 
studies with the human FEM models have been published in the context of various TES and 
TMS paradigms [58, 68, 91, 96, 117, 124, 131, 137, 150, 151, 228, 232-234, 236-240]. However, 
there remains a dearth of modeling effort using the animal models such as NHP [82] or mouse 
[241], although the utility of these animal models of transcranial stimulation is increasing to help 
to understand the biophysical mechanisms of transcranial stimulation techniques [82, 226, 241].  
In the present study, we develop realistic volume conductor modeling of the four NHP 
heads incorporating tissue heterogeneity and tissue conductivity anisotropy using the finite 
element method (FEM). We utilize individual-specific NHP models to compute the spatial 
distribution of the electric field strength generated by a right unilateral (RUL) ECT electrode 
configuration. We investigate the effect of anatomical differences on the electric field strength in 
the brain across four subjects at a fixed stimulus current amplitude. We also aim to derive an 
empirical estimate of the neural activation threshold by coupling the simulated electric field 
strength with individually-titrated RUL TES MT and to evaluate how well a simple TES MT 
titration procedure could be used for individualizing the current amplitude by accounting for 
individual anatomical variability in a NHP model of ECT. Finally, we test whether individual 




structural MRI data and subject-specific electric field simulation models. Our findings could be 
further used with realistic human models [68] and in clinical studies to explore novel ECT 
dosing paradigms, and as a novel noninvasive means to determine individual dosage requirement 
for ECT. Preliminary results from this study were previously presented in part in conference 
proceedings [242]. 
 
5.2. Materials and Methods 
We simulated the electric field induced by RUL TES in realistic finite element NHP head models 
using the same methods described in Chapter 2. The modeling methods are described in detail in 
Chapter 2 and are summarized here.  
 
5.2.1. TES Finite Element Model Generation  
The generation of a NHP head model started with preprocessing of the structural T1-weighted 
MRI images. As a first step, we extracted the monkey head regions from background noise and 
artifacts using a morphological processing technique including thresholding, opening, and 
closing of the head binary masks [6]. The head MRI images were upsampled (0.5×0.5×0.5 mm
3
 
voxel) and were spatially oriented along manually-defined anatomical landmarks, corresponding 
to anterior commissure, posterior commissure, and fiducials for inter-hemispheral midline. The 
MRI image intensities were corrected for bias field inhomogeneity [11]. We then applied 





content details and enhancing tissue boundaries [9]. Finally, non-brain regions were removed 
using the skull-stripping algorithm in FSL [10]. As a second step, we implemented an automatic 
algorithm that adopts the “unified segmentation” approach in SPM8 [12]. The de-skulled MRI 
images were automatically segmented into tissue probability images corresponding to gray 
matter, white matter, and cerebrospinal fluid (CSF) based on the macaque tissue priors [13]. The 
non-brain regions were manually segmented into 11 different tissue compartments, including 
skin, muscle, skull spongiosa, skull compacta, vertebrae, spinal cord, lens, eyeball, sclera, optic 
nerve, and sinus, using an in-house segmentation algorithm and the ITK-SNAP software [14]. As 
a third step, we modeled the RUL electrode placement which is standard in clinical ECT. The 
electrodes are round with a diameter of 2.5 cm diameter (half of the diameter of human 
electrodes due to the smaller size of the NHP head). One electrode was centered 1.25 cm to the 
right of vertex and the second electrode was placed in the homologous right frontotemporal 
position (see Figure 5.1). The contact surface between each electrode and the skin was defined 
by the outer surface of the NHP head. As a last step, we applied adaptive finite element meshing 
technique to the individual NHP head models incorporating the stimulation electrodes. The 
individual-specific TES finite element models of the four heads were created by means of the 
restricted Delaunay tessellation algorithm [15], each consisting of approximately 1.8 million 
tetrahedral elements. 
 
5.2.2. Electric Field Computation 
We created volume conductor head models by assigning anisotropic electrical conductivities to 




isotropic electrical conductivity values are listed in Table 2.1 [6]. The conductivity tensors in the 
white matter were computed using the volume normalized approach [16, 17], where the 
eigenvalues of the conductivity tensor match the eigenvalues of the diffusion tensor, and the 
conductivity tensor is scaled so that its volume equals that of an isotropic conductivity tensor 
with conductivity given in Table 2.1 (volume constraint).  
Each of the realistic TES finite element models along with the electrical conductivity 
values was imported into the finite element analysis software ANSYS (ANSYS Inc., 
Canonsburg, PA, USA). Due to the low frequency content (< 10 kHz) of the stimulus current of 
conventional TES and ECT devices, the quasi-static approximation can be deployed to simplify 
the electric field simulation by neglecting wave propagation, capacitive, and inductive effects 
[105, 243]. Thus, the electric field solutions were obtained by solving the Laplace equation with 
no internal sources [68]. The linear equation system of the finite element method was solved 
using the preconditioned conjugate gradient solver (relative tolerance=1×10
-8
) within ANSYS. 
The electric field distribution was determined by taking the gradient of the scalar potential V. 
 
5.2.3. In Vivo Motor Threshold Titration   
We determined the MT corresponding to the amplitude of a single TES pulse required to elicit a 
motor response in sedated NHPs [226]. The NHP subjects were sedated with ketamine (5–10 
mg/kg i.m.) and xylazine (0.35–0.7 mg/kg i.m.) [44]. The electrode sites were prepared by 
cleaning with alcohol to remove scalp oils and then rubbing with an abrasive gel (NuPrep, 
Weaver & Co., Aurora, CO) to reduce impedance. Thymapad adhesive electrodes (Somatics, 





amplitude of single stimulus pulses (pulse width = 0.2 ms) delivered through the RUL ECT 
electrodes with a DS7AH high-voltage constant-current stimulator (Digitimer, Welwyn Garden 
City, Hertfordshire, UK). Electromyography (EMG) was measured with needle electrodes from 
the first dorsal interosseous (FDI) muscle in the left hand, since the RUL electrode configuration 
predominantly stimulates the right hemisphere [68]. We determined the MT as the lowest 
stimulus pulse amplitude needed to achieve a 50 V peak-to-peak motor evoked potential (MEP) 
for at least five out of ten trials [244]. In each subject, the MT was titrated three times on three 
separate days. Each titration session included determination of two MTs corresponding to the 
two current polarities applied to the electrodes, which were then averaged to produce a single 
MT value per session. This average bidirectional MT is relevant to ECT since the ECT stimulus 
consists of current pulses with alternating polarity [111].  
 
5.2.4. Neural Activation Threshold Estimation 
Individual neural activation threshold was estimated from the median electric field strength in 
the FDI representation of motor cortex at the stimulus pulse amplitude corresponding to the 
individual MT. To sample the simulated electric field in the FDI regions, we created an 
anatomical template map that includes the FDI areas, which were manually delineated on the 
published macaque brain “F99” atlas [245] based on the rhesus macaque brain stereotaxic atlases 
[246, 247] and the web-based Scalable Brain Atlas (http://scalablebrainatlas.incf.org). The 
primary motor cortical representation area of the hand at the precentral gyrus “hand knob” was 
determined from coronal MRI slices and verified in the axial plane [248, 249]. For segmentation 




(ROI) segmentation using subroutines of SPM8 (http://www.fil.ion.ucl.ac.uk/spm). Each 
individual brain volume was warped to the atlas template in the least squares sense, thus 
minimizing the sum of squares difference between the subject and template image. This process 
computed a spatial transformation matrix that best registers the individual brain volume to the 
template [76]. Subsequently, the brain volume was aligned to the template map enclosing the 
FDI labels, and each voxel was labeled with the FDI structure label using the transformation 
matrix. Finally, the individual FDI volume labels were created by transforming back into the 
native space through the inverse of the deformation field.  
 
5.2.5. Anatomical Predictors of Motor Threshold 
To identify anatomical predictors of the individual MT, we examined relations between the 
individual average MT and electrode-to-cortex distance under the electrode centers, skin-to-
cortex distance at vertex, brain volume, and the ratio of the electrode current to the median FDI 
electric field strength. The Pearson’s linear correlation coefficient was computed for correlation 
analysis. 
 
5.2.5.1. Tissue Thickness 
Since the tissue thickness between the electrode and cortex is a critical determinant of the 
amount of stimulus current reaching the cortex [116, 250], we examined the relations between 
the measured MT and the electrode-to-cortex distance under the electrode centers as well as the 





dimensions using the outer skin and cortical surface meshes. The distance from slice views in 
two dimensions would result in overestimation of the skin-to-cortex distance, since a closer 
distance could be found out-of-plane [251]. Therefore, for each node on the tessellated skin 
surface, we searched for the intersection along the direction of the surface normal at that node 
and the cortical surface. The skin-to-cortex thickness was then determined as the shortest 
distance between the two surfaces [252].   
 
5.2.5.2. Brain Volumes 
Volumes of gray and white matter and extracerebral CSF excluding lateral ventricles were 
computed by multiplying the mean voxel value across the partial volume image by the total 
volume of that image (total volume = number of voxels × voxel size (0.5×0.5×0.5 mm
3
)). The 
total brain volume was determined by summation of each tissue volume fraction, finally divided 
by 1000 to obtain brain volume in milliliters (mL). 
 
5.2.5.3. Electrode-current to electric-field-strength Ratio 
Based on the FEM model simulations, we calculated the ratio of the electrode current to the 
median FDI electric field strength, Ielectrode/EFDI, for each subject. This ratio is expected to be 
correlated with the individual MTs since it characterizes the amount of current that has to be 
applied so that the FDI region in motor cortex reaches an approximately fixed neural activation 
threshold. The underlying assumption here is that the electric field threshold for neural 
activation, estimated by the median EFDI value at the individually-titrated MT current, is 








5.3.1. Individual TES Head Models 
The four individualized NHP head models (subjects MA, CH, DY, and RZ) used for the TES 
electric field simulation are displayed in Figure 5.1. The segmented tissue regions corresponding 
to skin, muscle, vertebrae, skull compacta, sclera, gray matter, lens, eyeball, optic nerve, spinal 
cord, and white matter as well as the RUL electrode montage are labeled in Figure 5.1. Inter-
electrode (electrode center-to-center) geodesic distances for subjects MA, CH, DY, and RZ were 
estimated to be about 53.7, 46.7, 57.9, and 47.3 mm, respectively, due to interindividual 
differences in anatomy between the four subjects. 
 
5.3.2. Interindividual Variations in Electric Field 
Strength  
The interindividual variation in electric field strength due to the anatomical differences between 
the subjects was investigated at fixed current amplitude of 800 mA (conventional current 
amplitude for ECT). Figure 5.2 shows descriptive statistics (1st, 25th, 50th (median), 75th, and 
99th percentiles) of the electric field strength in the left and right brain regions for the four 





median electric field in the right and left brain are summarized in Table 5.1. Subject RZ has the 
highest median electric field strength (1.59 V/cm), whereas subject CH has the lowest electric 





Figure 5.1. Individual TES head models of the four subjects (MA, CH, DY, and RZ, top to 
bottom rows, respectively). The various conductivity compartments are labeled including (a) 
RUL stimulation electrodes and tissue segmentation masks including (b) skin, (c) muscle, (d) 
vertebrae, (e) skull compacta, (f) sclera, (g) gray matter, (h) lens, (i) eyeball, (j) optic nerve, (k) 





Figure 5.2. Descriptive statistics of the electric field strength in the left and right brain regions 
induced by the RUL electrode configuration at 800 mA current for the four NHP subjects. The 
electric field strength (y-axis) is shown on a logarithmic scale to normalize the skewed electric 
field distribution. Boxes indicate the interquartile range (25th to 75th percentile) with the median 
marked by a horizontal line, and whiskers delimit the 1st and 99th percentiles of the electric field 




Table 5.1. Median electric field strength (V/cm) in the whole brain and right-to-left brain median 
electric field ratio induced by RUL TES at 800 mA. 
Subject Whole brain Right/left brain electric field ratio  
MA 1.46 1.68 
CH 1.01 1.54 
DY 1.44 1.89 





5.3.3. Neural Activation Threshold  
The electric field threshold for neural activation was empirically estimated by coupling the 
simulated electric field strength induced in the brain with the measured MT. Figure 5.3(a) shows 
the RUL TES MTs for each subject. The average MT across the four NHP subjects is 80.33 mA, 
with a range of 50–120 mA (2.4-fold variation) and coefficient of variation of 0.37. The repeated 
measures analysis of variance (ANOVA) analysis of the combined dataset from all MT titration 
sessions yielded a significant difference on MTs between the four subjects (F = 18.65, df = 3, p = 
0.0006). Figure 5.3(b) shows the corresponding estimates of the electric field threshold for neural 
activation for each subject, which are also summarized in Table 5.2. The average electric field 
threshold across the four NHP subjects is 0.45 V/cm (standard deviation = 0.07, coefficient of 
variation = 0.16). A comparison of the mean threshold values between the subjects shows that 
subject CH has the highest electric field threshold (0.52 V/cm), whereas subject MA has the 
lowest electric field threshold (0.35 V/cm). We found no significant effect of NHP subject on the 








Table 5.2. Individual neural activation threshold (V/cm) for the four NHP subjects. SD: standard 
deviation 
 MA CH DY RZ Mean (SD) 








Figure 5.3. (a) Individual amplitude-titrated RUL TES motor threshold (MT) for 0.2 ms pulse 
width for the four NHP subjects. (b) Corresponding estimated electric field neural activation 
threshold in the motor cortex representation of FDI. Bars show mean values and error bars show 
standard deviations. An asterisk represents significant difference between the NHP subjects at a 







5.3.4. Electric Field Distribution at Motor Threshold 
Figure 5.4 shows a set of representative views for the spatial electric field magnitude distribution 
at current strength corresponding to the individual MT for the four NHP subjects. The results in 
Figure 5.4 demonstrate that, as expected, the lateralized RUL electrode configuration 
predominantly stimulates the upper regions of the right hemisphere, thus yielding stronger 
electric field magnitude most localized to the right FDI areas of the motor cortex. Nevertheless, 
the detailed distribution of the electric field is complicated due to the complex electrical 
conductivity structure of the head and interindividual variations in the head anatomy.  
 
5.3.5. Anatomical Correlates of Motor Threshold 
Figure 5.5 shows individual maps of the distance from the skin surface to the cortex surface in 
the four subjects. The maps of the skin-to-cortex distance clearly indicate individual differences 
in anatomy. There are also differences in the skin-to-cortex distance at various points on the 










Figure 5.4. Electric field distribution at current strength corresponding to the individual MT for 
the four NHP subjects (top to bottom rows, respectively). Shown are electric field maps on the 
cortical surface (CSF–gray matter interface; first column), white matter surface (gray matter–
white matter interface; second column), representative coronal slice (third column), and 
transaxial slices (fourth to six columns; 1.5 mm inter-slice distance). The structural MRI images 
of the extracerebral brain tissues are shown in gray around the slices as a reference to the 
anatomical results in Figure 5.6. Region-of-interest outlines in white show FDI motor area. 







Figure 5.5. Maps of the distance from the skin surface to the cortex surface plotted overt eh head 
surface for the four subjects.  
 
Figure 5.6 shows the correlation between the measured MT and various anatomical and 
electric field model measures. There are strong correlations (r
2
 > 0.92, p < 0.05) between the 
measured MT and the superior electrode-to-cortex distance, vertex-to-cortex distance, brain 
volume, and Ielectrode/EFDI ratio computed from the individual FEM simulation. On the other hand, 
there was no significant correlation between MT and the electrode-to-cortex distance for the 
right frontotemporal electrode (r
2 
= 0.27, p = 0.476), which is 2–4 times further from the cortex 






Figure 5.6. Correlation between average measured MT and electrode-to-cortex distance under (a) 
superior or (b) frontotemporal electrodes, (c) vertex-to-cortex distance, (d) individal brain 
volume, and (e) Ielectrode/EFDI ratio computed from individual TES simulation models. Pearson’s 
correlation r
2






5.4. Discussion and Conclusions 
We presented an optimized processing pipeline intended particularly for generating an 
anatomically realistic FEM forward model of the NHP head incorporating complex tissue 
geometries and white matter anisotropic conductivities. Our modeling platform can be also used 
for modeling of other forms of brain stimulation such as TMS and transcranial direct current 
stimulation (tDCS). The spatial distribution of the electric field in a realistic NHP head model 
generated by TES has not been directly investigated. In this study, using the model developed, 
we (i) computed the spatial distribution of the electric field induced by the RUL ECT/TES 
electrode configuration in four NHP heads, (ii) examined the influence of anatomical differences 
on the electric field strength in the brain across multiple subjects at a fixed TES current 
amplitude, (iii) estimated the neural activation threshold by coupling the simulated electric field 
strength with individually-titrated RUL TES MT, and (iv) showed that individual anatomical 
variability as captured by structural MRI and the electric field model predicts individual 
differences in MT. This work represents the first computational study investigating the electric 
field characteristics of TES with RUL electrode configuration concurring with ECT stimulation 







5.4.1. Interindividual Variation in Electric Field 
Strength Stemming from Anatomical 
Variability 
Our findings clearly reveal that the spatial distributions of the electric field vary due to 
anatomical differences across four NHP subjects. The results shown in Figure 5.2 (1.6-fold 
variation in electric field strength in the whole brain) are consistent with a published modeling 
study in the context of transcranial direct current stimulation (tDCS) that reported 1.5-to-3-fold 
variations in peak cortical current density in normal human subjects [231], and extra ~10% 
variability in peak cortical current density by virtue of the head fat in obese individuals [234]. 
Moreover, it was reported that head anatomy difference resulted in ~2.4-fild variation in peak 
cortical electric field strength during tDCS in healthy human individuals [228]. It is well-
established that variations in head anatomy and tissue layer thickness influence the electric 
field/current density fields in the brain during TES [116, 231, 234, 253]. Our results support that 
morphological and anatomical difference in head anatomy is a significant source of the electric 
field/current density variability in TES. As such, applying the identical stimulus current 
amplitude and electrode montage to varied populations, such as distinct age or gender groups, 
can result in variable patterns of electric field/current density in the brain, yielding inconsistent 
clinical outcomes that include therapeutic efficacy and adverse side effects. In this regard, we 
have proposed that individualizing and lowering current amplitude could serve as a means of 





excitability, thus expecting to reduce side effects and clinical outcome variability [111, 116, 226, 
227]. 
 
5.4.2. Neural Activation Threshold 
Based on the individual MTs of the left FDI muscle and the individual realistic electric field 
models, the neural activation threshold was estimated to be 0.45  0.07 V/cm for the 0.2 ms 
rectangular pulses. The electric field threshold from previous studies using TMS with a figure-8 
coil ranges from 0.3 to 1.3 V/cm [254-257]. The MT elicited by TES in anesthetized humans 
produced the electric field threshold range of 0.45-1.12 V/cm for the 0.05 ms pulse width [258]. 
Despite differences in stimulation modality or stimulus current parameters (e.g., pulse wide and 
current amplitude/polarity), our estimates of the electric field threshold for neural activation are 
consistent with previous modeling and experimental measurements [254-258]. On the other 
hand, our previous work reported the neural activation threshold estimate as 0.29 V/cm for the 
0.2 ms pulse width [117]. This value is lower than the average electric field threshold (0.45 
V/cm) estimated in the present study. This discrepancy could be explained by the fact that the 
results in that study were estimated based on the average human TMS MT data for the figure-8 
coil from the literature.  
We observed the variation in the neural activation threshold (16%) across subjects that is 
smaller than the variation in the MT (37%), indicating that the individualized FEM models 
indeed account for interindividual differences in head anatomy. Further, possible errors in the 
modeling of the precise electrode position on the scalp may yield errors in the electric field 




explained by individual differences in neural excitability or brain anatomy in the FDI motor area, 
and/or to modeling errors. Furthermore, we cannot exclude that neural stimulation may have 
occurred along the corticospinal tract away from the cortical representation of FDI. Nevertheless, 
the strong correlation between the MT and the electric field in the cortical FDI control area as 
well as the superior-electrode-to-cortex and vertex-to-cortex distances, as shown in Figure 5.6, 
does support cortical origin of the MEPs.  
 
5.4.3. Individual Differences in TES MT are 
Correlated with Anatomical Variability 
The MT is traditionally used to measure the excitability of cortical neurons and corticospinal 
pathways in TMS studies despite a remarkable variation both within an individual subject and 
between subjects [259]. It is already used as a standard in the TMS field to standardize the 
simulation intensity across subjects [235]. It has been reported that the coil-to-cortex distance or 
scalp-to-cortex distance affect the MT in response to TMS [260-266]. Individual scalp-to-cortex 
distance has been considered as a significant determinant of interindividual variations in TMS-
elicited MT [263-267]. In addition to previous studies based on TMS, it is of particular interest to 
study whether individual differences in MT elicited by TES could be explained by individual 
anatomical variability. To address this question, here we examined the correlation between 
several anatomical variables and individually determined MT data. We found that interindividual 
variation of the TES-elicited MT is significantly correlated with the variation in skin-to-cortex 





skin-to-cortex distance under the right frontotemporal electrode center. The lack of correlation 
between individual MT and the distance between the frontotemporal electrode and cortex could 
potentially be explained by the significantly larger electrode-to-cortex distance at that location 
compared to the vicinity of vertex. This may be due to the large lateral muscles in the NHP head, 
which result in less penetration of the electrode current into the intracranial space at lateral in 
comparison to superior locations. The large variations of the skin-to-cortex distance at superior 
and lateral regions are clearly shown in Figures 5.4 and 5.6(a). This may also relate to the longer 
distance between the lateral electrode and the FDI cortical motor area. The distance between the 
electrode and cortex is a critical anatomical parameter to determine the optimal TES current, 
since electrical current delivered by TES travels through the various head tissue compartments, 
as shown in Figure 5.1, to excite sufficient volume of the brain. If the electrode-to-cortex is 
small, low stimulus current will be sufficient to elicit the physiological activity, whereas the 
identical current will not induce any activity at longer distance.  
Of note, this study revealed that the Ielectrode/EFDI ratio determined using individualized 
electric field models is significantly correlated with individual MT. This strong correlation 
between the MT and the simulated Ielectrode/EFDI ratio suggests that the subject-specific 
computational models could predict variations in the individual current required for neural 
stimulation in TMS, ECT and in other transcranial stimulation applications. These findings do 
suggest that to compensate for individual anatomical variability, either individual MRI, 
individual MT, or individual electric field simulation could be used to choose the individual ECT 





5.4.4. Limitations and Future Work 
Several potential limitations need to be addressed. First, despite potential significance of the 
present study, possible source of errors related to use of electric field models includes 
uncertainty in tissue electrical conductivity. It is well-established that the accuracy of the electric 
field/current density fields induced in the head by TES is influenced by tissue electrical 
properties [68, 98, 116, 235]. Since direct and non-invasive in-vivo conductivity measurements 
still remain a challenging problem, a number of published modeling studies have used a wide 
range of tissue conductivity values reported in the literature. It should be noted that variation in 
tissue conductivity can contribute to inaccuracies of the simulated electric field/current density 
fields in the head. Furthermore, other important factors (e.g., tissue segmentation or head 
anatomy variations) that are potential sources of electric field/current density variability in the 
modeling studies were discussed in our previous paper (for the details see [68]). Nevertheless, in 
this paper the NHP head models incorporating the realistic WM anisotropic conductivity 
distributions and isotropic conductivities are sufficient to predict the electric field spatial 
distributions in an individual basis. In addition, the strong correlation between individual MT 
and the Ielectrode/EFDI ratio determined from the RUL TES focal stimulation indirectly supports the 
validity of our developed model [228, 232, 233].  
Second, the small number of subjects in the present study could affect the correlation and 
statistical analyses. Based on our correlation results from four NHP subjects, our interpretation 
concerning the issue if individual anatomical variability is predictive of individual differences in 
TES MT should be cautious in drawing generalized conclusion. Nonetheless, we presented 
significant strong correlations between individual anatomical factors and individual MT. We also 





individual FEM computational models for each subject based on the individual MRI and DTI. 
Therefore, we believe the present results do provide important insight that can be confirmed and 
expanded in future studies in larger populations. 
We also estimated the neural activation threshold that is independent of the electric field 
direction. It is known that the electric field direction relative to the stimulated neural population 
may influence the neural activation threshold [117, 214]. Inclusion of the electric field direction 
would affect our estimates of neural activation threshold, thus the spatial patterns of electric field 
stimulation strength estimate. Nevertheless, as discussed in section 5.4.2, this study represents 
the first attempt at deriving the neural activation threshold by linking empirically measured MT 
with the simulated electric field magnitude from the realistic NHP models. If the electric field 
direction data becomes available in future studies, it can be easily incorporated with our electric 
field models. Our model incorporating white matter anisotropic conductivity can also provide 
more accurate electric field directional information compared to the model with fully isotropic 
conductivity. 
In summary, we developed the high-resolution individual-specific FEM models of the 
NHP heads for the purpose of predicting the electric field strength in the brain generated by the 
RUL electrode configuration. Knowledge of the electric/current density field characteristics 
derived from such realistic head models can help to interpret the existing ECT paradigms, and 
can be useful in optimizing stimulation techniques. This study indeed presents that the NHP 
animal models could be used to characterize the induced electric field distributions in the brain at 
individually-titrated MT and to derive an empirical estimate of the electric field threshold for 




may guide the development of a novel therapeutic intervention for the treatment of major 










Chapter 6  
Electric Field Characteristics of  
ECT with Individualized Current 
Amplitude 
6.1. Introduction 
Electroconvulsive therapy (ECT) remains the most effective treatment for severe major 
depression [79, 80]. ECT induces a generalized seizure under anesthesia by delivering electric 
current to the brain via electrodes placed on the scalp. However, the biophysical mechanisms 
responsible for the effects of ECT are still unknown, and the use of ECT is impeded by cognitive 
side effects such as amnesia [20]. Various ECT technique modifications have been proposed to 
reduce adverse side effects of ECT while maintaining therapeutic efficacy. For example, the shift 
from sine wave to rectangular brief pulses [27, 107, 268] as well as the shift from brief to 
ultrabrief pulse width [36, 269, 270] resulted in diminished side effects of ECT without 
sacrificing efficacy. Moreover, high dose right unilateral (RUL) ECT represented a comparable 




Bifrontal (BF) and an experimental frontomedial (FM) configuration have been proposed to 
preferentially focus the electric field in prefrontal regions to maximize efficacy and limit side 
effects [79, 227, 271]. However, there is still limited knowledge of how to optimally determine 
the dosing of ECT. The ECT dose includes electrode placement/shape and stimulus current 
parameters (e.g., current amplitude or polarity) that affect the electric field induced in the brain 
[111]. The distribution of the electric field in the brain also depends upon the geometry of the 
head and electrical properties of head tissues [68, 116, 117, 227].  
In practice, ECT is applied with a fixed high current amplitude of 800 or 900 mA for all 
patients [111]. The high, fixed current amplitude in conventional ECT produces widespread 
direct stimulation in the brain that exceeds the neural activation threshold by several fold, 
potentially contributing to side effects [68, 111, 117, 217]. Furthermore, using a fixed current 
amplitude in conventional ECT for all patients may lead to variable clinical outcomes due to 
individual anatomical and neurophysiological variation [111]. Indeed, there is considerable 
variability in clinical outcomes, including efficacy as well as adverse cognitive side effects, 
which at present do not have a known anatomical or physiological explanation. Therefore, we 
have proposed that lowering and individualizing stimulus current amplitude could serve as a 
means of reducing side effects and clinical outcome variability [217, 226, 227, 271]. Reduced 
ECT current amplitude improves the focality of stimulation, potentially decreasing side effects of 
seizure therapies [111, 217, 227, 272, 273]. Lowering the current amplitude could avoid direct 
hippocampal stimulation, potentially reducing adverse effects on memory [274]. However, the 
capability of these paradigms to focus on the electric field strength coupled with in vivo 





Knowledge about the strength and spatial distribution of the electric field induced by 
ECT may help to unravel the mechanisms determining the efficacy and side effects seen with 
various ECT paradigms, and may inform novel techniques for improvement of spatial targeting 
of ECT which could lead to improved risk/benefit ratio [68]. However, the electric field 
distribution alone is insufficient to characterize the degree of induced neural stimulation, since 
the neural response is also dependent on other parameters such as the pulse shape and width 
[111, 117]. To overcome this limitation, we proposed previously, using a spherical head model, 
an electric field model incorporating a waveform-specific neural activation threshold to 
determine the suprathreshold direct stimulation strength and volume (focality) in ECT [117, 
217]. This approach allows us to reveal what brain areas are directly stimulated by various 
stimulation modalities, and to compare stimulations with different pulse characteristics such as 
between brief and ultrabrief pulse ECT [117]. The spherical model consisting of several layers of 
concentric spheres, however, cannot account for detailed anatomical tissue features, individually 
variable head geometries, and anisotropic tissue properties. The electric field solution computed 
from significantly simplified spherical model is approximate. Thus, the interpretation about the 
electric field characteristics in the brain generated by the spherical electric field model should be 
careful, and simple extrapolation from the spherical head modeling studies may be inadequate. 
Furthermore, that study used a neural activation threshold estimated from the literature.  
Investigations using invasive or noninvasive brain stimulation techniques in macaques have 
provided us with extensive knowledge about the functional or structural organization of the 
primate brain. The macaque monkey model has been becoming a rational basis for much of our 
understanding of the human brain. Indeed, nonhuman primate (NHP) models have proven to be 




for optimizing ECT stimulation parameters for efficient seizure induction [226], and for 
characterizing neurophysiological effects of  electrically and magnetically induced seizures 
[230].  
In this Chapter, we aim to investigate the electric field characteristics of various forms of 
ECT with individualized current amplitude in four NHP subjects. The electric field distributions 
in the brain induced by the various ECT modalities including the BL, BF, RUL, and FM ECT 
electrode configurations are computed in anatomically realistic finite element models of four 
NHP heads. We estimate the neural activation threshold from individually measured motor 
threshold (MT) and simulated electric field strength. For each ECT electrode configuration, we 
determine the stimulation strength and focality relative to an empirical electric field threshold for 
neural activation at individually-titrated seizure threshold (ST) and at fixed current amplitude 
corresponding to the average ST. We quantify the focality of stimulation to evaluate the effect of 
the stimulus current amplitude on the brain volume stimulated above the neural activation 
threshold. Understanding the induced electric field characteristics and their individual variability 
could help identify potential causes of the differences in clinical outcome, and could support the 
development of ECT dosing paradigms with fewer side effects. Preliminary results from this 
study were previously presented in part in conference proceedings [227, 273]. 
 
6.2. Materials and Methods 
We simulated the electric field induced by ECT in realistic finite element NHP head models 
using the same methods described in Chapters 2 and 5. The modeling methods are described in 





6.2.1. ECT Head Model Generation 
In Chapters 2 and 5, we described an optimized processing pipeline for generating a realistic 
finite element model of a NHP head incorporating tissue heterogeneity and tissue conductivity 
anisotropy [227, 273]. The processing framework consists of four main components: image 
preprocessing, tissue segmentation, stimulation electrode placement, and finite element mesh 
generation.  
The preprocessing of the structural MRI images includes image resampling (0.5×0.5×0.5 
mm
3
 voxel), anterior and posterior commissures (AC-PC) spatial alignment, bias field correction, 
nonlinear anisotropic diffusion filtering, and skull stripping [71, 227]. Next, individual tissue 
probability maps corresponding to gray matter, white matter, and cerebrospinal fluid (CSF) were 
automatically produced using SPM8 (Wellcome Department of Cognitive Neurology, Institute of 
Neurology, University College London, UK, http://www.fil.ion.ucl.ac.uk/spm) based on the 
112RM-SL macaque tissue priors [77]. Manual segmentation of the non-brain regions into 11 
tissue compartments, representing skin, muscle, skull spongiosa, skull compacta, vertebrae, 
spinal cord, lens, eyeball, sclera, optic nerve, and sinus, was carried out using a combination of 
tools from the ITK-SNAP software [75] and an in-house morphological processing algorithm 
[57, 68, 71]. Subsequently, we modeled three standard ECT electrode placements (BL, BF, and 
RUL) [79, 80] and an investigational configuration (FM). Two round electrodes were modeled 
for the BL (3.5 cm diameter) and BF, RUL, and FM (2.5 cm diameter, respectively) ECT 
configurations (see Figure 6.1). For BL ECT, the two electrodes were placed bilaterally at the 
frontotemporal positions located at 2 cm above the midpoint of the line connecting the external 
canthus and tragus [80]. For BF ECT, the electrodes were positioned bilaterally 2.5 cm above the 




placed in the right frontotemporal position and the other electrode was centered 1.25 cm to the 
right of vertex [80]. For FM ECT, the two electrodes were placed medially on the forehead and 
posterior to vertex, respectively. Finally, adaptive finite element meshes were generated for each 
subject using the restricted Delaunay tessellation algorithm [88], resulting in the four subject-
specific ECT finite element models of the rhesus macaque heads and electrodes, each consisting 
of approximately 1.8 million tetrahedral elements.  
 
6.2.2. Electric Field Computation 
To compute electric field strength induced by each of the four different ECT electrode 
configurations, the dielectric properties of tissues were incorporated into the ECT models. The 
volume conductor models were created by assigning the anisotropic electrical conductivities into 
the white matter regions, and the isotropic conductivities into all the other tissue compartments. 
The isotropic electrical conductivity values are listed in Table 2.1. The white matter anisotropic 
conductivity tensors were derived by means of a direct transformation approach with volume 
normalization [57, 93-97]. The electric field distribution in each ECT head model was obtained 
by solving the quasi-static Laplace equation using the preconditioned conjugate solver with a 
relative tolerance of 1×10
-8
 within ANSYS (ANSYS Inc., Canonsburg, PA, USA) [68].  
 
6.2.3. In Vivo Motor and Seizure Threshold Titration 
Four different ECT electrode montages for in vivo MT and ST titration experiments 





methodology of titrating MT and ST in NHPs was previously published by our group [226, 273, 
274]. In summary, we determined the MT corresponding to the amplitude of a single pulse 
required to elicit a motor response in sedated NHPs, and the ST corresponding to the amplitude 
for a train of pulses to elicit a seizure in the same session for each of the ECT electrode 
configurations [226]. The NHP subjects were sedated with ketamine (5–10 mg/kg i.m.) and 
xylazine (0.35–0.7 mg/kg i.m.) [44]. The electrode sites were prepared by cleaning with alcohol to 
remove scalp oils and then rubbing with an abrasive gel (NuPrep, Weaver & Co., Aurora, CO) to 
reduce impedance. Thymapad adhesive electrodes (Somatics, LLC, Lake Bluff, IL) were cut 
down to 3.5 cm circles for BL and 2.5 cm circles for BF, RUL, and FM. MT and ST were titrated 
by stepping current amplitude (pulse width = 0.2 ms) in the anesthetized NHPs. For MT, 
electromyography was measured with needle electrodes from the first dorsal interosseous (FDI) 
muscle in both hands for all ECT conditions, but only from the left hand in the RUL ECT 
condition since the stimulation is predominantly unilateral in the right hemisphere [68]. The MT 
was determined for both current polarities. The MT was defined as the minimum stimulus pulse 
amplitude needed to achieve a 50 V peak-to-peak motor evoked potential (MEP) for at least 
five out of ten trials.  
ST was determined by an ascending method-of-limits titration of the stimulus pulse 
amplitude, while holding all the other stimulus parameters fixed. The stimulus train consisted of 
500 pulses delivered at 50 pulses per second resulting in train duration of 10 s. ST titrations for 
BL and RUL ECT used unidirectional pulse trains (cathode on right side) whereas the ST 
titrations for BF and FM ECT used a conventional bidirectional train (alternating pulse polarity). 




EEG as a secondary criterion. The MT and ST titration was repeated three times for each ECT 
condition in each subject. 
 
6.2.4. Stimulation Strength and Focality Analysis 
In addition to the electric field magnitude, other stimulation factors affecting neural response 
include pulse amplitude, shape, and width, and train frequency and duration [111]. The impact of 
the pulse waveform characteristics such as pulse shape and width on the induced electric field by 
ECT has been discussed in our previous study [111]. In this study, we aimed to examine the 
effect of pulse stimulus amplitude on the electric field strength and directly activated brain 
volume above threshold. The electric field magnitude is directly proportional to the ECT 
electrode current [111]. We calibrated the electric field magnitude to an empirically-derived 
neural activation threshold, Eth, by normalizing the electric field spatial distribution to that 
threshold, E/Eth. Such calibration of the electric field distribution to an empirically determined 
neural response threshold can largely take into account the various factors affecting the neural 
response listed above, and can partially compensate for inaccuracies in the tissue property 
modeling [111]. An individual neural activation threshold, Eth, was determined from the median 
electric field strength in the FDI representation of the motor cortex at stimulation current 
corresponding to the individual MT for the RUL electrode configuration, which produces electric 
field distribution most localized to the FDI areas [68, 227]. The electric field at threshold 
produces a weak motor response corresponding to the recruitment of a small fraction of neurons 





determined based on the monkey brain stereotaxic atlases [246, 247] and the Scalable Brain 
Atlas (http://scalablebrainatlas.incf.org).  
We generated maps of the electric field strength relative to the threshold for neural 
activation by dividing the electric field magnitude distribution in the brain by the electric field 
magnitude corresponding to threshold motor response, and determined the stimulation strength 
and focality at individualized current amplitude corresponding to ST for each ECT electrode 
configuration in the four NHP subjects [117, 227]. This metric reflects the approximate level of 
neuronal depolarization relative to the action potential threshold [111, 117]. We quantified the 
focality of stimulation by the percentage of the brain volume that is exposed to electric field 
strong enough to produce suprathreshold depolarization in the majority of neurons, i.e., the 
volume where E/Eth ≥ 1 [117, 227]. In addition, we evaluated the effect of current amplitude on 
the percentage brain volume stimulated above the electric field threshold as a function of current 
amplitude. Finally, to test whether current amplitude individualization could reduce inter-
individual variability in head anatomy and neurophysiological excitability, we compared the 
coefficient of variation of the stimulated brain volume among the four subjects for individualized 
ST current amplitude as well as for fixed current amplitude corresponding to the average ST. 
 
6.2.5. Finding Electric Field Correlates to Individual 
Differences in ECT Seizure Threshold 
To test the hypothesis whether individual differences in ECT ST is predicted by subject-specific 




the median electric field strength in the whole brain, Ielectrode/Ebrain, for each ECT electrode 
configuration in each subject. This ratio characterizes individual amplitude-titrated ST variability 
from the ECT electric field simulation models, because the electric field strength in the entire 
brain was determined from the individual electric field model simulations, thereby reflecting 
individual anatomical variability. We then evaluated a linear correlation between Ielectrode/Ebrain 




6.3.1. Individual ECT Head Models  
The individual ECT head models used for the electric field simulation are displayed in Figure 
6.1. Figure 6.1 shows the simulated conventional ECT electrode configurations including BL, 
BF, and RUL, as well as an investigational configuration of FM ECT in one representative NHP 
head model (subject CH). The segmented tissue regions corresponding to skin, muscle, 
vertebrae, skull compacta, sclera, gray matter, lens, eyeball, optic nerve, spinal cord, and white 






Figure 6.1. Representative individualized ECT models (subject CH) for the bilateral 
frontotemporal (BL), bifrontal (BF), right unilateral (RUL), and frontomedial (FM) ECT 
electrode configurations (left and middle columns). The various conductivity compartments are 
labeled including (a) ECT stimulation electrodes and tissue segmentation masks including (b) 
skin, (c) muscle, (d) vertebrae, (e) skull compacta, (f) sclera, (g) gray matter, (h) lens, (i) eyeball, 
(j) optic nerve, (k) spinal cord, and (l) white matter (right column).  
 
6.3.2. Electric Field Distribution Relative to Neural 
Activation Threshold 
Table 6.1 gives the individually measured RUL MTs and the amplitude-titrated STs for the four 




averages of the three measurements. Based on the median electric field strength in the FDI area 
for RUL at MT, we estimated the individual neural activation threshold to be Eth = 0.35, 0.52, 
0.44, and 0.48 V/cm for subject MA, CH, DY, and RZ, respectively. Average electric field 
threshold for neural activation across four subjects is 0.45 V/cm (standard deviation = 0.07). The 
individual electric field threshold for each subject was used to determine the electric field 
stimulation strength and focality for all ECT electrode configurations.  
 Figure 6.2 shows maps of the E-field strength relative to the neural activation threshold at 
current strengths corresponding to individually amplitude-titrated STs (see Table 6.1) for the 
various ECT electrode configurations in the four NHP models. The simulated conventional ECT 
electrode montages including BL, BF, and RUL, as well as an investigational configuration of 
FM ECT for sample subject CH are displayed (top row). The maps of the E-field magnitude 
distributions relative to the neural activation threshold at current amplitudes corresponding to 
individual STs are visualized on the surface (gray matter-white matter interface) as well as in a 
representative coronal slice for each individual subject. A qualitative comparison of the electric 
Table 6.1. Individually measured average motor threshold (mA) and average seizure threshold 
(mA) for the four ECT electrode configurations in the four NHP subjects. SD: standard deviation 
Subject 
Motor Threshold (mA) Seizure Threshold (mA) 
RUL BL BF RUL FM 
MA 0.43 111 89 107 89 
CH 0.32 215 190 284 141 
DY 0.0063 222 196 190 128 
RZ 0.04 164 146 141 92 







Figure 6.2. Electric field stimulation strength relative to neural activation threshold (Eth) at 
current amplitude corresponding to amplitude-titrated ST (see Table 6.1) for BL, BF, RUL, and 
FM ECT configurations (second to fifth columns, respectively) in four NHP models—subject 
CH, MA, DY, and RZ (top to bottom rows). Representative ECT simulation models (subject CH) 
are shown (top row). Electric field distributions relative to individual threshold at individual ST 
are plotted on the surface (gray matter-white matter interface) and in a representative coronal 
slice. The E/Eth color map is clamped at an upper limit of 2 for good visibility of the electric field 





field stimulation strength relative to the threshold for neural activation indicates that the 
symmetric ECT electrode configurations (BL, BF, and FM) stimulate comparable brain volume 
in both hemispheres. On the other hand, the asymmetric RUL electrode configuration directly 
activates the right brain regions while sparing the left brain sides.  
 
6.3.3. Effect of Current Amplitude 
Figure 6.3 shows the effect of current amplitude on the percentage of the brain volume with 
electric field strength above the neural activation threshold for the four ECT electrode 
configurations. Both averages and standard deviations of the stimulated brain volume above 
threshold across four subjects are plotted for all ECT electrode configurations. At individual STs 
(100% ST), the results in Figure 6.3(a) indicate that BL ECT stimulates, on average, the largest 
brain volume (63 ± 10%), whereas RUL ECT produces the most focal stimulation (25 ± 7%). An 
experimental FM configuration at ST stimulates the brain volume (36 ± 14%) that is slightly 
smaller than that by BF ECT (40 ± 11%). The induced electric field distributions vary linearly 
with current amplitude. Thus, the electric field stimulation strength relative to the neural 
activation threshold and directly stimulated brain volume are controlled by the current amplitude. 
As a result, the directly stimulated brain volume above threshold increases with higher current 
amplitude as shown in Figure 6.3(b), indicating that lowering the current amplitude reduces the 
activated brain volume. Consistent with the results in Figure 6.3(a), BL ECT activates the largest 








Figure 6.3. Effect of current amplitude on the percentage directly stimulated brain volume above 
the neural activation threshold (E ≥ Eth) (a) at individual STs (100% ST) and (b) as a function of 
current amplitude (pulse width = 0.2 ms) relative to the neural activation threshold for the BL, 
BF, RUL, and FM ECT electrode configurations. In (a), averages and standard deviations (error 
bars) of directly stimulated brain volume at individual STs across four subjects for each ECT 
electrode configuration are plotted. In (b), each color band represents the averages (solid lines) 
and standard deviations (shades) of the percentage stimulated brain volume across four subjects 





6.3.4. Effect of Current Amplitude Individualization 
Figure 6.4 compares the coefficient of variation of the stimulated brain volume above the 
threshold among four subjects between ECT with individualized and group-average (fixed) ST 
current amplitude. Group-average ST current strengths for each ECT electrode configuration 
were used as the fixed current amplitude for estimating the directly stimulated brain volume 
above threshold (see Table 6.1). The results in Figure 6.4 indicate that for all ECT electrode 
configurations, individualized current amplitude results in less variability of the stimulated brain 
volume across subjects (16-39%) compared to ECT with fixed, average ST current amplitude 
(29-64%).  
 



































Figure 6.4. Comparison of coefficient of variation of the stimulated brain volume above 
threshold among four NHP individual models between ECT with individual and group-average 





6.3.5. Electric Field Correlates of Individual 
Differences in ECT Seizure Threshold 
The interindividual variation in electric field strength due to the differences in head anatomy and 
size between the four subjects was examined at fixed current amplitude of 800 mA. Figure 6.5 
shows averages and standard deviations of the median electric field magnitude in the whole brain 
across four NHP models. The averages of the median electric field strength across four subjects 
are 2.2, 1.9, 1.4, and 2.6 V/cm for the BL, BF, RUL, and FM ECT electrode configurations, 
respectively. Furthermore, we found that there is 1.22-, 1.47-, 1.57-, and 1.90-fold variation in 
the median electric field magnitude between the four individual subjects for the BL, BF, RUL, 
and FM electrode configurations, respectively. The variation of the electric field magnitude 
implies the variability of the electric field characteristics in the brain due to the head anatomical 
differences. Using the electric field strength in the whole brain at simulated electrode current, we 
tested the hypothesis if individual differences in ECT ST can be explained by the individual 
electric field variability.   
Figure 6.6 shows the correlation between the Ielectrode/Ebrain ratio computed from the 
individual ECT simulation models and the amplitude-titrated ST. We found there is no 
significant correlation between the individual electric field strength and individual ST data, but 
there is a positive correlation trend (r
2
=0.665-0.902) for all electrode configurations that does not 



































Figure 6.5.  Averages and standard deviations (error bars) of the median electric field strength in 
the whole brain across four NHP head models at 800 mA current.  
 
 
Figure 6.6.  Correlation between amplitude-titrated ST and Ielectrode/Ebrain ratio computed from 





6.4.  Discussion and Conclusions 
Even though the electric field strength is thought to play a key role in seizure induction in ECT 
technique, it has not been completely understood. The spatial distributions of the induced electric 
field strength by various ECT electrode configurations determine which brain regions are 
directly stimulated for seizure induction. The stimulus current amplitude is a critical aspect of 
dosage in ECT, as it controls the electric field magnitude and the volume of brain tissues directly 
activated by the electric stimulation delivered by different ECT electrode montages. The impact 
of individualizing and reducing current amplitude on the magnitude and distributions of the 
electric field induced by ECT has not been fully characterized, while ECT with low, 
individualized current amplitude is still capable of inducing a generalized seizure, potentially 
minimizing adverse side effects of ECT. This work represents the first quantitative study 
investigating the electric field characteristics of ECT with low, individualized current amplitude 
using anatomically-realistic computational NHP head models by combining with 
neurophysiological measurements acquired during in vivo MT and ST titration procedures.  
 
6.4.1. Implications for ECT Dosing 
Findings from the present study support the view that ECT induces the electric field distribution 
in the brain that varies in strength depending upon the ECT stimulus parameters including the 
position of stimulation electrodes, stimulus pulse amplitude, as well as pulse shape and width 
[68, 111, 117, 217]. Our results, shown in Figure 6.2, confirm that the spatial distributions of the 




head, which is consistent with previous studies [68, 111, 217]. The results are further associated 
with the electrical responses of neuronal membranes. The externally applied electric fields by 
ECT affect neural activity by depolarizing and hyperpolarizing neuronal membranes [111]. 
Stimulation with extracellular electric fields leads to the depolarization of a large number of 
neurons, resulting in modulation of the neural activity and seizure induction [41, 111]. In this 
respect, the novelty of this study is that the electric field distributions resulting from various ECT 
paradigms were computed from the anatomically-accurate head models of four different NHP 
subjects, each with incorporating the individually measured MT and ST data that represent 
neurophysiological responses, in order to examine the benefits of individualizing and lowering 
current amplitude in ECT. This was achieved by quantifying and comparing the strength and 
focality of stimulation, which was estimated by comparing the electric field strength to an 
estimate of the threshold for neural activation. There has been no modeling study dedicated to 
investigating the advantages of individualizing and lowering current amplitude as a novel means 
of improving the safety of seizure therapies. The understanding of the electric field 
characteristics of various forms of ECT is of particular importance for unraveling the 
mechanisms of action of ECT and for optimizing its dosage.  
The electric field distribution and individual MT and ST were utilized to estimate the 
strength of stimulation and directly stimulated brain volume above threshold for seizure 
induction. Using the median electric field strength in the left FDI motor area determined from the 
most focal stimulation (RUL ECT) as well as the individual MT data, we estimated the neural 
activation threshold to be 0.45  0.07 V/cm for the 0.2 ms rectangular pulses. Our estimates of 
electric field threshold for neural activation are consistent with published estimates of threshold 





albeit differences in the stimulus parameters (e.g., pulse width, frequency, and number of pulses) 
and other factors of the ECT procedure (e.g., anesthesia) [111]. As proposed here, calibrating the 
electric field solution to an empirical estimate of the neural activation threshold could largely 
compensate for modeling errors from the quasistatic assumption, so that we could reveal what 
regions of the brain respond to the induced electric fields and are directly activated by various 
stimulation modalities. We could further determine what the delivered dosage is relative to the 
neural activation threshold. The electric field stimulation strength exposure of specific brain 
areas is electrode montage and current amplitude specific, as illustrated in Figures 6.2 and 6.3. 
The results in Figure 6.2 demonstrate different electric field stimulation characteristics in the 
brain resulting from the various ECT electrode configurations even when the current strength is 
at the lowest level required to induce a seizure (ST). Different electric field patterns suggest 
different loci of seizure induction which may be important for focal brain stimulation. Thus, our 
study demonstrates the utility of the physiologically-calibrated computational electric field 
models to analyze various stimulus delivery paradigms, and may inform improved ECT 
technique with individually-titrated dosage.  
It has been reported that conventional ECT delivered with high, fixed current amplitude of 
800/900 mA results in excessive direct brain stimulation at markedly suprathreshold levels, 
potentially contributing to adverse side effects [68, 111, 117, 217]. A substantial number of early 
experimental studies have been published in order to address that generalized seizures could be 
induced with lower current amplitudes than traditional high current levels [268, 271, 275-277]. 
Our results in 6.3(a) show that the largest portion of the brain is directly stimulated by BL ECT 
even at the lowest current strength that induces a seizure (63  10%). In contrast, the RUL ECT 




and electric field distribution shifted to the right hemisphere, thereby sparing left hemisphere 
regions from side effects of stimulation (see Figure 6.2). An important observation from our 
results is that seizure induction with a combination of a relatively focal electrode configuration 
(RUL) and individually titrated current (ST) produces an electric field distribution with 
magnitude below the neural activation threshold in, on average, about 75% of the brain. This 
suggests that the regions of the brain that may be critical to cognitive side effects such as the left 
temporal lobe may be spared, since the electric field strength there is well below the neural 
activation threshold, potentially minimizing adverse side effects of ECT. On the other hand, the 
robust therapeutic effectiveness of BL ECT may stem from the relatively even spread of the 
electric field and associated large volume of stimulated brain tissues even at ST. The 
experimental FM configuration with the goal of targeting frontal and superficial brain regions 
stimulated a slightly smaller brain volume (36  14%) at ST than BF ECT (40  11%), which is 
also designed to target the prefrontal cortex to reduce memory impairment. However, whether 
the FM electrode configuration can be used as a means of enhancing antidepressant efficacy and 
reducing adverse effects is not known yet. Therefore, further clinical studies should evaluate the 
therapeutic efficacy and adverse effect profile of FM ECT with potentially reduced and 
individualized current amplitude.  
Notably, the stimulated brain volume at amplitude-titrated ST are substantially smaller 
than the brain volume stimulated with conventional high, fixed current amplitude that may reach 
as high as 100% [68, 117, 217, 274]. Computational human modeling studies using the spherical 
and realistic head models demonstrated an excessive stimulation of large portions of the brain at 
fixed current amplitude of 800 mA, the average of stimulated brain volume is 94%, 84%, and 





modeling results shown in Figure 6.3(b) show the effect of current amplitude on the percentage 
volume of brain directly activated. Increasing the current amplitude by a factor of 2 (200% ST) 
stimulated 1.6-2.9 times larger brain volume compared to 100% ST. At the 2×ST current levels, 
on average, about 98% of the brain volume was exposed to suprathreshold electric field in BL 
ECT, whereas about 71% of the brain was stimulated by RUL ECT, producing the most focal 
stimulation even at 2×ST compared to the other electrode configurations. Figure 6.3(b) also 
demonstrates that reducing current amplitude decreases the activated brain volume. In support of 
our findings, a recent pilot clinical study reported that seizures were successfully induced in 
several patients by an investigational electrode configuration for focal electrically administered 
seizure therapy (FEAST), which is similar to our FM configuration, with current amplitude as 
low as 400 mA [220]. Another case study with 5 patients showed that generalized seizures were 
induced by the RUL electrode configuration with 500 mA stimulus current, which is just more 
than half of conventional level of 800 or 900 mA [271]. As such, the electric field magnitude in 
the brain induced by ECT with higher currents significantly exceeds the neural activation 
threshold, potentially higher than necessary for seizure induction. Seizures, in turn, can be 
generated with lower currents, corresponding to more focal stimulation than those in standard 
ECT practice. This modeling study suggests that the focality of stimulation can be enhanced by 
means of reduction of the current amplitude along with the use of focal electrode configurations, 
thereby achieving more targeted stimulation in ECT. All these observations may provide a 
rational basis for future clinical studies with various electrode placements and lowered current 
amplitude. Future work will evaluate the clinical impact of such manipulations. 
The fixed current amplitude used in present clinical ECT for all patients results in variable 




and anatomy [111, 116, 226]. As indicated in Table 6.1, there is a substantial individual 
variability in ST value across subjects. This motivates that ECT stimulus amplitude should be 
individualized. The objective of current amplitude adjustment would be to obtain comparable 
intracranial electric field characteristics for various subjects. Figure 6.4 indicates that ECT with 
individualized ST current strength results in variation in the brain volume stimulated above the 
neural activation threshold across subjects that is ~1.6–1.9 times smaller than the variation for 
fixed, average ST current strength. This suggests that current amplitude individualization could 
be a means of compensating for interindividual variability in anatomy and neurophysiological 
excitability. Individualizing current amplitude further improves consistency in delivered dose. 
This observation supports exploring individualization of the ECT stimulus current amplitude in 
clinical studies. Therefore, ECT with low, individualized current should be evaluated as a means 
of reducing side effects and outcome variability in clinical studies. 
Since the subject-specific model captures the individual anatomical variability, the 
computational electric field model developed here can be potentially used to estimate the 
selection of the stimulus current amplitude for dose individualization. Our results in Figure 6.5 
indicate that different electric field characteristics in the brain arise due to interindividual 
variations in head anatomy between four NHP subjects. Based on these individual electric field 
estimates, we tested if the individual electric field models can be used to predict individual 
variations in amplitude-titrated ST. As shown in Figure 6.6, we found no significant correlation 
between estimate of individual amplitude-titrated ST variability from individual electric field 
models and amplitude-titrated ST for all ECT electrode configurations likely due to a small 
number of subjects. However, we observed that there is a positive correlation trend (r
2
=0.665-





between subjects. Our results demonstrate that anatomical variability is a primary factor driving 
individual differences in ST, and thus dosing requirements for ECT. This suggests that the 
individual electric field model could be used as a predictor of ST to individualize the stimulus 
current amplitude in ECT without the need to induce a seizure. Moreover, individual dosage 
requirement can be predicted by titrating MT without having to induce a seizure, since 
amplitude-titrated ST and MT are strongly correlated [226]. Both MT titration and individual 
electric field modeling approaches should be evaluated whether those can serve as safer 
alternatives to empirical ST titration for dosage individualization.  
 
6.4.2. Limitations and Future Work 
As previously discussed by our group [68], any modeling study has several limitations. As the 
accuracy of the electric field or current density fields in the brain generated by electrical 
stimulation is limited by accurate representation of head anatomy and dielectric properties of the 
tissues, errors may arise from a limited number of tissues as well as uncertainty in their electrical 
conductivity values [68]. However, our electric field modeling approach that couples with 
empirical data of MT and ST (see Section 2.6) could partially compensate for possible errors in 
the tissue property modeling [111]. The threshold for neural activation estimated here is 
independent of the direction of electric field, which is known to affect the neural activation 
threshold [214, 278-280]. However, if precise electric field threshold data of the other brain 
regions of interest relative to motor cortex, which also can take into account the electric field 
direction relative to activated neural population, becomes available in the future, they can be 
easily incorporated with our model [111]. Future studies will need to integrate the actual neural 




optimizing treatment parameters of seizure therapies and maximizing its antidepressant effects. 
Finally, our conclusion from a pilot correlation study is limited due to the small sample size. As 
discussed in Section 4.1, non-significant results are likely due to the small number of subjects, 
which precludes any generalized conclusions. Nevertheless, there do appear to be a positive 










Chapter 7  
Electric Field Characteristics of  
MST with Individualized Current 
Amplitude 
7.1. Introduction 
Electroconvulsive therapy (ECT) remains the most effective treatment and rapidly acting 
antidepressant for severe major depression [79], but its cognitive side effects may be persistent 
[20]. Various improvements in ECT technique have reduced its side effects without sacrificing 
efficacy [38, 281, 282]. Modifications in ECT technique that resulted in diminished side effects 
include pulse shape – shift from sine wave to rectangular brief pulses [26-28] and shift from brief 
to ultrabrief pulse width [29, 283, 284], electrode placement – introduction of right unilateral 
(RUL) [31, 32, 282], and individualized dosage – with dosing the number of pulses relative to 
individual seizure threshold (ST) [35, 38, 285]. Despite these successful modifications in ECT 
technique, its adverse side effects still arise in many patients. As an alternative form of 




seizure induction for therapeutic efficacy while lowering adverse cognitive side effects 
associated with ECT. MST involves the induction of a therapeutic seizure in patients under 
anesthesia using repetitive transcranial magnetic stimulation (rTMS). Recent studies suggest that 
MST can deliver focal brain stimulation that produces the electric field confined to superficial 
cerebral cortex and offers a higher side effect profile than conventional ECT [1]. 
Conventional ECT is applied with a fixed high current amplitude (800 or 900 mA) that 
results in excessive direct stimulation in the brain than necessary electric field neural activation 
threshold [86], possibly contributing to adverse side effects of ECT. Recent studies suggest that 
pulse current amplitude in convulsive therapy be lowered and individualized to improve the 
risk/benefit ratio of convulsive therapy and to reduce clinical outcome variability [111, 226]. 
This view is supported by observations that ECT with lower, individualized current amplitude 
could improve spatial targeting of electric field and compensate for individual anatomical 
variability [227, 273, 274]. Previously, in multiple nonhuman primate (NHP) models we 
examined the suprathreshold direct stimulation strength and volume (focality) of various forms 
of ECT with individualized current amplitude corresponding to amplitude-titrated seizure 
threshold (ST) measured in the anesthetized NHPs [227, 273]. However, that study estimated the 
neural activation threshold under the ECT conditions and the electric field characteristics of 
MST with individualize current amplitude have not been investigated directly.  
In this Chapter, the strength and spatial distribution of the electric field generated by a 
cap (CAP) MST coil configuration are computed in anatomically realistic finite element models 
of the four NHP subjects. We estimate the electric field neural activation threshold in the motor 
cortex by coupling the simulated electric field strength with in vivo MT data measured with the 





empirical electric field neural activation threshold at individualized current amplitude 
corresponding to amplitude-titrated ST. We examine the impact of lowering and individualizing 
current amplitude on the stimulated brain volume. Understanding the induced electric field 
characteristics and their individual variability could help identify potential causes of the 
differences in clinical outcome, and could support the improvement of MST dosing paradigms 
with reduced side effects.  
 
7.2. Materials and Methods 
We simulated the electric field induced by MST in realistic finite element NHP head models 
using the same methods described in Chapters 2 and 6. The modeling methods are described in 
detail in Chapters 2 and 6 and are summarized here.  
 
7.2.1. MST Head Model Generation  
We constructed realistic finite element models of the four healthy male rhesus macaques 
(Macaca mulatta) from T1-weighted magnetic resonance imaging (MRI) and diffusion tensor 
imaging data sets. We modeled a cap (CAP) coil (MagVenture A/S, Farum, Denmark) 
configuration using manufacturer’s data and inductance measurements. The CAP coil consists of 
a single-layer, concave circular winding with an inner diameter of 21 mm, outer diameter of 95 
mm, and 15 turns (see Figure 7.1). The coil conductors were centered above the vertex of the 




7.2.2. Electric Field Computation 
All tissue regions were considered electrically isotropic except the white matter. We used tissue 
electrical conductivity values given in Table 2.1 for the isotropic tissue compartments. To derive 
the white matter conductivity tensors with variable anisotropy ratios, we deployed the volume 
normalization technique using the measured diffusion tensors and the isotropic white matter 
conductivity value given in Table 2.1. The electric field solutions generated by CAP MST at the 
output of the MagPro MST device were acquired using the electromagnetic time-harmonic solver 
of ANSYS (ANSYS Inc., Canonsburg, PA) with appropriate boundary conditions in each NHP 
subject (see Chapter 2 for details).  
 
7.2.3. In Vivo Motor and Seizure Threshold Titration 
Both the TMS MT and MST ST procedures were carried out using a MagPro MST device with a 
CAP coil (MagVenture A/S, Farum, Denmark). The coil induced in the head a cosine current 
pulse with clockwise initial phase direction and a 0.36 ms period. The coil was centered at the 
vertex of the head, as illustrated in Figure 7.1. Stimulus intensity was reported as percentage of 
maximum pulse amplitude (% MA). Maximum pulse amplitude corresponds to 1,800 V peak 
coil voltage. We determined the MT corresponding to the amplitude of a single TMS pulse 
required to elicit a motor response in sedated NHPs [226]. The NHP subjects were sedated with 
ketamine (5–10 mg/kg i.m.) and xylazine (0.35–0.7 mg/kg i.m.) [44]. In each subject, the 
individual MT was determined as the lowest stimulus pulse amplitude needed to achieve a 50 V 





out of ten trials [244]. ST was titrated by increasing the stimulus pulse amplitude in percentage 
of maximum pulse amplitude in MST while holding all the other stimulus parameters were fixed 
(50 pulses/s, 10 s train duration). We confirmed seizures by observing the motor seizure 
manifestations in the left arm and the EEG as a secondary criterion. The MT and ST titration was 
repeated three times on three separate days in each subject. 
 
7.2.4. Stimulation Strength and Focality Analysis 
An individual neural activation threshold was derived from the median electric field strength in 
the FDI representation of the motor cortex at current amplitude corresponding to the individual 
MT given in Table 7.1. This threshold electric field strength was compared to an estimate from 
the literature, Eth = 1.18 V/cm for CAP MST [117]. We determined maps of electric field 
stimulation strength relative to individual electric field threshold by dividing the electric field 
magnitude distribution in the brain by the threshold, E/Eth [5, 6]. We quantified the focality of 
stimulation by the percentage of the brain volume that is exposed to electric field strong enough 
to produce suprathreshold depolarization, i.e., the volume where E/Eth ≥ 1 [6].  
 
7.3. Results 
7.3.1. Neural Activation Threshold 
We estimated the electric field threshold for neural activation by coupling the simulated electric 




MT for left and right hands and average ST values for the CAP MST coil configuration, which 
are also plotted in Figures 7.1(a)–(c), respectively. All values in Table 7.1 are the averages of 
three measurements. CAP MST MTs in the left hand were used to derive the estimates of electric 
field threshold for neural activation. The average MT in the left hand across the four NHP 
subjects is 21%, with a range of 16–24 mA (1.5-fold variation) and coefficient of variation of 
0.16. The repeated measures analysis of variance (ANOVA) analysis of the combined dataset 
from all CAP MST titration sessions resulted in a significant difference on MTs (left hand: F = 
11.51, df = 3, p = 0.0028; right hand: F = 90.52, df = 3, p = 1.63e-6) and STs (F = 11.45, df = 3, 
p = 0.0029) between the four NHP subjects. Figure 7.1(d) shows the corresponding estimates of 
the electric field threshold for neural activation for each subject, which are also summarized in 
Table 7.2. The average electric field threshold across the four NHP subjects is 0.77 V/cm 
(standard deviation = 0.06, coefficient of variation = 0.07). A comparison of the electric field 
threshold values in Figure 7.1 and Table 7.2 shows that subject CH has the highest electric field 
threshold (0.85 V/cm), while subject MA has the lowest electric field threshold (0.72 V/cm). We 









Figure 7.1.  Individual amplitude-titrated CAP MST motor threshold (MT) for (a) left and (b) 
right hands as well as (c) seizure threshold (ST) for the four NHP subjects. (d) Corresponding 
estimated electric field neural activation threshold in the motor cortex representation of FDI. Bar 
show mean values and error bars show standard deviations. An asterisk represents significant 







7.3.2. Electric Field Distribution Relative to Neural 
Activation Threshold 
Figure 7.2 shows the simulated CAP MST coil configuration for the four NHP subjects (subjects 
MA, CH, DY, and RZ), and corresponding cortical surface maps as well as coronal cross-
sectional maps of the electric field distributions relative to the neural activation threshold (Eth) at 
current strengths corresponding to amplitude-titrated STs (see Table 7.1).  
Table 7.1. Individually measured average motor threshold (%) for left (L) and right (R) hands 
and average seizure threshold (%) for the CAP MST coil configuration in the four NHP subjects. 
SD: standard deviation 
Subject 
Motor Threshold (%) 
Seizure Threshold (%) 
L Hand R Hand 
MA 16 16 30 
CH 24 28 43 
DY 20 19 37 
RZ 22 22 39 




Table 7.2. Individual neural activation threshold (V/cm) for the four NHP subjects. SD: standard 
deviation 
 MA CH DY RZ Mean (SD) 







 Figure 7.3 shows descriptive statistics (1st, 25th, 50th (median), 75th, and 99th percentiles) of 
the electric field magnitude relative to the neural activation threshold at individual ST for the 
four NHP subjects. At individual ST, subject DY has the highest median electric field strength 
relative to threshold (0.62), whereas subject CH has the lowest strength value (0.38), resulting in 
1.6-fold variation in the whole brain across the four NHP subjects. The median MST induced 
electric field strength ranges from 0.4 to 0.6 times threshold.  
 
 
Figure 7.2. Simulation models of CAP MST for the four NHP subjects (top row, subjects MA, 
CH, DY, and RZ). Electric field stimulation strength relative to neural activation threshold (Eth) 
at current amplitude corresponding to amplitude-titrated seizure threshold (ST) on the cortical 
surface (middle row) and in a representative coronal slice (bottom row). The E/Eth color map is 
clamped at an upper limit of 2 for good visibility of the distribution of electric field stimulation 





Figure 7.3. Descriptive statistics of electric field magnitude relative to neural activation threshold 
at individual ST for the four NHP subjects. The electric field stimulation strength (y-axis) is 
known on a logarithmic scale to normalize the skewed electric field distribution. Boxes indicate 
the interquartile range (25th to 75th percentile) with the median marked by a thick horizontal 
line, and whiskers delimit the 1st and 99th percentiles of the electric field distribution.  
 
7.3.3. Effect of Current Amplitude 
Figure 7.4 shows the effect of current amplitude on the percentage of the brain volume with 
electric field above the neural activation threshold for the four NHP subjects. At individual STs, 
the results in Figure 7.4(a) show that subject RZ has the largest stimulated brain volume (27%), 
whereas subject CH has the lowest activated brain volume (18%). The average of directly 
activated brain volume is 23% (standard deviation = 4, coefficient of variation = 0.17) across the 
four NHP subjects. The results in Figure 7.4(b) show that the stimulated brain volume above 






Figure 7.4. Effect of current amplitude on the percentage directly stimulated brain volume above 
the neural activation threshold (E ≥ Eth) (a) at individual STs (100% ST) and (b) as a function of 
current amplitude relative to the neural activation threshold for CAP MST. Red color band 
represents the average (solid line) and standard deviation (shade) of the percentage stimulated 






7.3.4. Effect of Current Amplitude Individualization 
Figure 7.5 compares the coefficient of variation of the stimulated brain volume above the neural 
activation threshold among the four NHP subjects between MST with individualized versus 
group-average (fixed) ST current amplitude. Group-average ST current strength (37%) was used 
as the fixed current amplitude (see Table 7.1). The results in Figure 7.5 show that individualized 
current amplitude results in less variability of the stimulation brain volume across the four 
subjects (17%) compared to MST with the fixed, average ST current amplitude (23%).  
 
 
Figure 7.5. Comparison of coefficient of variation of the stimulated brain volume above the 
neural activation threshold among the four NHP subjects between MST with individual versus 










7.4. Discussion and Conclusions 
Understanding the electric field characteristics is of particular importance to unravel the 
mechanisms of therapeutic seizure induction in MST techniques, but it has not been completely 
understood. The impact of lowering and individualizing current amplitude on the magnitude and 
distribution of the electric field induced by MST has not been fully investigated. Therefore, this 
work represents the first quantitative study investigating the electric field characteristics of MST 
with individualized current amplitude using high-resolution anatomically accurate finite element 
models of the four NHP subjects and neurophysiological measurements acquired during in vivo 
MT and ST titration procedures. The results in Figure 7.2 demonstrate the electric field 
stimulation patterns in the brain at the lowest current strength required to induce a seizure (ST). 
These results indicate that CAP MST provides less intense and superficial stimulation, 
supporting that MST may reduce the cognitive side effects of convulsive therapy. This also 
suggests that MST can be used as a more focal stimulation form of seizure induction.  
We utilized the electric field distribution and individual MT and ST data to estimate the 
strength of stimulation and directly activated brain volume above threshold for seizure induction. 
Using the median electric field strength in the FDI motor area and the individual MT data, we 
estimated the neural activation threshold to be 0.77  0.06 V/cm, with a range of 0.72–0.85 
V/cm. Our estimates of electric field threshold for neural activation are consistent with published 
estimates of threshold electric field strength (0.3–1.3 V/cm) [254-257], indirectly supporting the 
validity of our MST electric field model. Furthermore, we found that our estimated average 
neural activation threshold (0.77 V/cm) is lower than an estimate (1.18 V/cm) from the literature 
[117]. This discrepancy may stem from the use of the average human TMS MT data by the 




Our results in Figure 7.4 demonstrate that the directly stimulated brain volume above the 
neural activation threshold is controlled by the current amplitude. The stimulated brain volume at 
amplitude-titrated ST is substantially lower than the brain volume activated with conventional 
fixed, high current amplitude that may reach as high as 100% [68, 117, 217, 274]. For example, 
at the 2×ST current level, our results show that about 46% of the brain volume was exposed to 
suprathreshold electric field. Increasing the current strength by a factor of 2 (200% ST) 
stimulated 2 times larger brain volume compared to 100% ST. Another important observation is 
that seizure induction with a combination of a CAP MST coil configuration and individualized 
current amplitude (ST) results in an electric field distribution with magnitude below the neural 
activation threshold in, on average, 77% of the brain. This suggests that direct stimulation of 
medial-temporal brain regions (e.g., hippocampus) that may be critical to cognitive side effects 
may be spared, since the electric field strength there is well below the neural activation 
threshold. This view is also supported by our findings in Figure 7.3 that the MST-induced 
median electric field strength relative to threshold is well below the neural activation threshold. 
MST with low, individualized current amplitude provides the electric field in the brain that does 
not exceed the threshold for neural activation, possibly reducing adverse side effects of 
convulsive therapy.  
The results in Figure 7.5 indicate that MST with individualized current amplitude results 
in variation in the brain volume stimulated above neural activation threshold across the four NHP 
subjects that is ~1.3 times smaller than the variation for fixed, average current strength. This 
suggests that current amplitude individualization could be used as a means of compensating for 





that MST with low, individualized current amplitude should be explored as a means of reducing 
side effects and outcome variability in clinical studies.  
 Taken together, these observations support exploring MST paradigms with low, 
individualized current amplitude as a potential means of reducing side effects. This work further 
demonstrates the utility of computational electric field models to examine the electric field 
stimulation strength and focality to provide insight into the mechanisms of therapeutic seizure 
induction, and could provide rational basis for future clinical investigation of MST with 










Contributions and Future Research 
Suggestions 
8.1. Contributions  
The objective of this dissertation was to develop a novel framework for the rational dosing of 
electric and magnetic seizure therapy to improve existing approaches for seizure therapies and to 
develop novel, safer and effective treatments for mental illness and inform the development of 
device-based therapies that better balance adverse effects and therapeutic outcomes. To this end, 
this work developed a new platform that couples computational modeling with in vivo empirical 
validation for the refinement of ECT/MST techniques. The present work supports the 
development of novel forms of seizure therapy with an improved side effect profile, thereby 
benefiting patients with severe psychiatric disorders.  
 Original contributions of this dissertation are that (1) it is the first application of 
individualized realistic 3-D head models to ECT/MST; (2) it couples computational modeling 
with in vivo empirically optimized pulse amplitude and train characteristics; (3) it involves 





through novel electrode/coil and current amplitude configurations (e.g., FEAST and FM ECT, 
and MST); (4) it entails interdisciplinary work between biomedical engineering and psychiatry, 
which has been lacking in the field of seizure therapies; (5) it may lead to entirely new and 
clinically feasible means of ECT/MST dosing paradigms thus potentially improving their 
risk/benefit ratio; (6) computational modeling tools develop here have a broad impact beyond 
seizure therapies, because they can be applied to they can be applied to aid field shaping for 
subconvulsive applications of the recently FDA-approved transcranial magnetic stimulation 
(TMS) and transcranial direct current stimulation (tDCS) as well. The key findings of the 
dissertation are summarized below:  
In Chapter 2, we developed anatomically realistic finite element models using high-
resolution structural MRI and DTI data of human and NHPs for transcranial electric and 
magnetic stimulation. The NHP models of transcranial brain stimulation were constructed 
alongside the human model since NHPs are used in preclinical studies on the mechanisms of 
seizure therapy.     
In Chapter 3, we presented the first computational study investigating the electric field 
(E-field) strength generated by various ECT electrode configurations in specific brain regions of 
interest (ROIs) that have putative roles in the therapeutic action and/or adverse side effects of 
ECT. This study also characterized the impact of the white matter conductivity anisotropy on the 
electric field distribution. A finite element head model incorporating tissue heterogeneity and 
WM anisotropic conductivity was constructed based on structural MRI and DTI data. We 
computed the spatial electric field distributions generated by three standard ECT electrode 
placements including BL, BF, and RUL and an investigational electrode configuration for focal 




electric field strength over the whole brain is 3.9, 1.5, 2.3, and 2.6 V/cm for the BL, BF, RUL, 
and FEAST electrode configurations, respectively, which coupled with the broad spread of the 
BL electric field suggests a biophysical basis for observations of superior efficacy of BL ECT 
compared to BF and RUL ECT; (2) in the hippocampi, BL ECT produces a median electric field 
of 4.8 V/cm that is 1.5–2.8 times stronger than that for the other electrode configurations, 
consistent with the more pronounced amnestic effects of BL ECT; and (3) neglecting the white 
matter conductivity anisotropy results in electric field strength error up to 18% overall and up to 
39% in specific ROIs, motivating the inclusion of the white matter conductivity anisotropy in 
accurate head models. This computational study demonstrates how the realistic finite element 
head model incorporating tissue conductivity anisotropy provides quantitative insight into the 
biophysics of ECT, which may shed light on the differential clinical outcomes seen with various 
forms of ECT, and may guide the development of novel stimulation paradigms with improved 
risk/benefit ratio.  
In Chapter 4, we examined the characteristics of the electric field induced in the brain by 
ECT and MST. The electric field induced by five ECT electrode configurations (bilateral, 
bifrontal, right unilateral, focal electrically administered seizure therapy, and frontomedial) as 
well as an MST coil configuration (circular) was computed in an anatomically realistic finite 
element model of the human head. We computed the maps of the electric field strength relative 
to an estimated neural activation threshold, and used them to evaluate the stimulation strength 
and focality of the various ECT and MST paradigms. The results show that the median ECT 
stimulation strength in the brain is 7–29 times higher than that for MST, and that the stimulated 
brain volume is substantially higher with ECT (47–100%) than with MST (4%). This study 





and supports arguments for lowering ECT current amplitude as a means of curbing its side 
effects. 
In Chapter 5, we derived an estimate of the electric field neural activation threshold and 
tested whether individual differences in TES MT can be predicted by individual anatomical 
variability as captured by structural MRI data and individualized electric field simulation 
models. The electric field distribution induced by a right unilateral (RUL) TES/ECT electrode 
configuration was computed in subject-specific finite element head models of four nonhuman 
primates (NHPs) for whom individual MT was measured. By combining the measured MTs with 
the computed electric field maps, the neural activation threshold was estimated to be 0.45  0.07 
V/cm for 0.2 ms stimulus pulse width. The individual MT was correlated with the electrode-to-
cortex distance under the superior electrode (r
2
=0.96, p=0.022) and at vertex (r
2
=0.96, p=0.022), 
as well as with the simulated electrode-current/induced-E-field ratio (r
2
=0.95, p=0.026), thus 
indicating that both individual anatomical variability and individualized electric field models 
could predict the individual current requirements for transcranial brain stimulation. These 
findings could be used with realistic human head models and in clinical studies to explore novel 
ECT dosing paradigms, and as a new noninvasive means to determine individual dosage 
requirement with ECT. 
In Chapter 6, we investigated the characteristics of the electric field induced in the brain 
by ECT with individualized current amplitude in nonhuman primate (NHP) models. The electric 
field spatial distributions of three conventional ECT electrode placements including bilateral 
(BL), bifrontal (BF), and right unilateral (RUL) and an investigational frontomedial (FM) 
configuration were computed in anatomically realistic finite element models of four NHP heads. 




threshold, and determined the stimulation strength and focality of the various ECT electrode 
configurations with individualized current amplitude corresponding to amplitude-titrated seizure 
threshold (ST) assessed in the anesthetized NHPs, as well as fixed current amplitude 
corresponding to average ST. The key results are that (1) at individual ST, the average of 
percentage brain volume stimulated above neural activation threshold is 63%, 40%, 25%, and 
36% for the BL, BF, RUL, and FM electrode configurations, suggesting that the focality of 
stimulation can be enhanced by reduction of the current amplitude along with the use of the focal 
electrode configuration; (2) ECT with individualized current amplitude results in less variation 
(16–39%) in stimulated brain volume above threshold compared to fixed, average current 
amplitude (29–64%), suggesting that current amplitude individualization results in more focal 
and uniform electric field exposure across different subjects, and can be used as a means of 
compensating for interindividual variability in anatomy and neurophysiological excitability. 
Understanding the stimulation strength and focality of various forms of ECT could provide 
insight into the mechanisms of therapeutic seizure induction, and could provide a rational basis 
for the clinical investigation of ECT with lowered and individualized current amplitude as an 
intervention with potentially improved risk/benefit ratio.    
In Chapter 7, we investigated the characteristics of the electric field induced in the brain 
by MST with individualized current amplitude in anatomically realistic nonhuman primate 
(NHP) head models. The electric field distributions induced in the brain by a cap (CAP) MST 
were simulated in realistic finite element models of the four NHP subjects. We created maps of 
the electric field strength relative to an empirical neural activation threshold, and determined the 
stimulation strength and focality of the CAP MST coil configuration with individualized current 





NHPs, as well as a fixed current amplitude corresponding to group-average ST. The key results 
are that (1) at individual ST, the average of percentage brain volume stimulated above neural 
activation threshold is 23%, suggesting that the focality of stimulation can be improved by 
lowering the current amplitude; (2) MST with individualized current amplitude results in less 
variation (17%) in stimulated brain volume above threshold compared to fixed, average current 
amplitude (23%), suggesting that current amplitude individualization results in more focal and 
uniform electric field exposure across different subjects, and can be used as a means of 
compensating for interindividual variability in head anatomy and neurophysiological excitability. 
Understanding the induced electric field characteristics and their individual variability could help 
identify potential causes of the variations in clinical outcome, and could support the development 
of MST dosing paradigms with reduced side effects. 
 
8.2. Suggestions for Future Research 
Some ideas of how the work in this dissertation can be extended were already discussed in the 
text. Here we attempt to summarize research directions for future work.  
 First, while computational models offer accurate insight into detailed electric 
field/current density field patterns, there are several sources of uncertainty that confound the 
conclusions of modeling studies. Uncertainty about the electrical properties of the various tissues 
in the model can contribute inaccuracies of the simulated electric field. The accuracy of electric 
field in the brain is also limited by the precision and accuracy of tissue segmentation. Although 
there has been no comprehensive effort for direct validation of the computational modes with 




forward models by comparing to neurophysiological measurements [232, 233]. However, there 
remains a dearth of experimental data validating direct model predictions of induced electric 
field in the brain. Techniques to experimentally validate the simulated electric field/current 
density field induced in the brain should be explored.  For example, current density imaging 
(CDI), which is a MRI technique used to quantitatively measure the magnitude and direction of 
current density vectors [286, 287], could be employed for experimental assessments.  
 Second, imaging of brain activity during transcranial electric and magnetic stimulation is 
of particular importance to facilitate the detection of psychiatric disorders and to advance our 
understanding of the mechanisms of therapeutic effects of psychiatric interventions. The electric 
field distribution is a key aspect of dosage for both ECT and MST and knowledge of this 
distribution may help to explain differences in efficacy and side effects seen with existing 
paradigms and may inform novel methods to improve spatial brain stimulation. However, the 
electric field alone is not sufficient to evaluate biological, functional, and behavioral effects. The 
combination of transcranial brain stimulation (e.g., ECT/MST) with other brain imaging 
modalities (e.g., diffusion tensor and functional MRI, electroencephalography or 
magnetoencephalography, single photon emission computed tomography) can provide insight 
into the effect of the induced electric field in the brain and may help to document large-scale 
stimulation-induced reorganization of structural and functional networks at rest or during task-
related activity [288]. Correlating the computational field models with imaging and 
electrophysiological measurements of brain activity should be explored.  
Third, future studies can also explore the incorporation of direction-sensitive neural 
activation threshold with our electric field models. The electric field threshold for neural 





field direction relative to the stimulated neural population may affect the neural activation 
threshold [214]. As such, the direction of the induced electric field is an important determinant of 
the effective stimulation strength and focality [223]. If the electric field direction data becomes 
available in future studies, it can be incorporated with our electric field models. The 
computational model with white matter anisotropic conductivity developed in Chapter 2 can also 
provide more accurate electric field directional information compared to the model with fully 
isotropic conductivity. The electric field characteristics of ECT/MST paradigms by linking with 
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